US20030229374A1 - Embolic protection system - Google Patents

Embolic protection system Download PDF

Info

Publication number
US20030229374A1
US20030229374A1 US10/435,661 US43566103A US2003229374A1 US 20030229374 A1 US20030229374 A1 US 20030229374A1 US 43566103 A US43566103 A US 43566103A US 2003229374 A1 US2003229374 A1 US 2003229374A1
Authority
US
United States
Prior art keywords
catheter
filter
medical device
collapsed
reception space
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/435,661
Inventor
Eamon Brady
Gary Fahey
Brendan Casey
Ann Cannon
David Vale
Martin Keegan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salviac Ltd
Original Assignee
Salviac Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29420459&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20030229374(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Salviac Ltd filed Critical Salviac Ltd
Priority to US10/435,661 priority Critical patent/US20030229374A1/en
Assigned to SALVIAC LIMITED reassignment SALVIAC LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRADY, EAMON, KEEGAN, MARTIN, CANNON, ANN MARIE, CASEY, BRENDAN, FAHEY, GARY, VALE, DAVID
Publication of US20030229374A1 publication Critical patent/US20030229374A1/en
Priority to US12/259,700 priority patent/US8123778B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0095Packages or dispensers for prostheses or other implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/0108Both ends closed, i.e. legs gathered at both ends
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/011Instruments for their placement or removal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0006Rounded shapes, e.g. with rounded corners circular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0008Rounded shapes, e.g. with rounded corners elliptical or oval

Definitions

  • This invention relates to an embolic protection filter, which is movable between a collapsed configuration for transport through a vasculature and an expanded configuration for deployment in a vasculature.
  • embolic protection filters with a biocompatible coating to minimise the risk of fibrin build-up on the filter, and the risk of clots forming in the blood stream.
  • biocompatible coatings have hydrophilic properties. These hydrophilic coatings interact with water molecules. Water molecules may be absorbed during manufacture, sterilisation, storage or in use. Often the quantity of water absorbed is low leading to the biocompatible coating swelling slightly, and the coating becoming sticky or tacky.
  • Filter membranes in this state have the potential for self-adherence and this can lead to the collapsed filter becoming stuck to itself in the collapsed configuration with the result that the filter will fail to expand fully, or even expand at all, when deployed in the vasculature. Failure of an embolic protection filter to correctly deploy in a vasculature can potentially lead to embolic material migrating downstream through the vascular system with potentially life-threatening consequences.
  • This invention is therefore aimed at overcoming at least some of the problems associated with known embolic protection systems.
  • An embolic protection system comprising:
  • an embolic protection filter having a collapsed delivery configuration and an expanded deployed configuration
  • a delivery catheter having a reception space, an embolic protection filter being housed in the collapsed configuration in the reception space of the delivery catheter;
  • a sealed sterile pouch housing the delivery catheter containing the filter in the collapsed configuration.
  • the filter in the collapsed configuration is at least partially folded.
  • system comprises an adhesion preventer to substantially prevent adhesion of adjacent folds of the filter to one another in the collapsed configuration.
  • adhesion preventing material is selected from one or more of:
  • the invention also provides a medical device movable between a collapsed configuration for transport through a vasculature and an expanded configuration for deployment in a vasculature:
  • the device having a collapsed configuration in which the device is at least partially folded and an expanded configuration:
  • the device comprising an adhesion preventer to prevent adhesion of adjacent folds of the device in the collapsed configuration to one another.
  • the device comprises a collapsible body and a support structure to support the body in the expanded configuration.
  • the collapsible body may be located at least partially externally of the support structure.
  • the support structure may be located at least partially externally of the collapsible body.
  • the adhesion preventer comprises means to space adjacent folds of the device apart.
  • the means to space adjacent folds of the device apart comprises a filler material applied to a surface of the device.
  • the filler material may comprise a silicon fluid, or a silicon gel, or a lipid filled fluid/gel, or a heparin filled fluid/gel, or an aqueous material.
  • the means to space adjacent folds of the device apart comprises one or more arms for extending between adjacent folds of the device.
  • the support structure may comprise the arm.
  • the arm is provided by a tool which is suitable to assist loading of the device into a catheter.
  • the biocompatible surface is provided as a coating of biocompatible material on the device.
  • the biocompatible surface may be provided on an external surface of the device.
  • the biocompatible surface may be provided on an internal surface of the device.
  • the invention provides a method for providing embolic protection during a vascular procedure comprising the steps of:
  • an embolic protection system comprising a sealed sterile pouch containing a delivery catheter with a reception space, an embolic protection filter being housed in the reception space in collapsed configuration;
  • the method comprises the step of flushing the filter in the collapsed configuration within the delivery catheter.
  • the filter is flushed prior to sealing of the pouch.
  • a medical device movable between a collapsed configuration for transport through a vasculature and an expanded configuration for deployment in a vasculature, the device comprising:
  • a storage space for storing a biocompatible material during transport through a vasculature
  • [0037] means to deliver the biocompatible material from the storage space to a surface of the device when deployed in a vasculature.
  • the storage space may be provided in a wall of the device.
  • the means to deliver the biocompatible material comprises one or more channels from the storage space to the surface of the device.
  • the channel is a capillary channel.
  • biocompatible material is delivered to an external surface of the device. In another case the biocompatible material is delivered to an internal surface of the device.
  • the device comprises a delivery actuator to at least partially cause delivery of the biocompatible material from the storage space to the surface of the device.
  • the actuator is at least partially of a temperature memory material.
  • the biocompatible material may be a hydrophilic material.
  • the device is an embolic protection filter.
  • the filter has an inlet end and an outlet end, the inlet end having one or more inlet openings sized to allow blood and embolic material enter the filter, the outlet end having a plurality of outlet openings sized to allow through passage of blood but to retain undesired embolic material within the filter.
  • the invention provides a method of loading a medical device into a catheter, the method comprising the steps of:
  • the medical device may be at least partially collapsed down by passing the medical device through a funnel.
  • the wrap of the medical device is at least partially controlled by formations on the funnel.
  • the medical device is at least partially collapsed down by directing a jet of fluid over the medical device.
  • the wrap of the medical device is at least partially controlled by directing a jet of fluid over the medical device.
  • the medical device is at least partially collapsed during positioning of the medical device at least partially within the catheter.
  • a system for loading a medical device into a catheter comprising:
  • [0052] means to collapse a medical device down to a wrapped configuration
  • [0053] means to control the wrap of the medical device.
  • the means to collapse comprises a funnel through which a medical device may be passed.
  • the means to control the wrap comprises one or more formations on the funnel.
  • the formation comprises an inward protrusion on a wall of the funnel.
  • the protrusion may be in the form of a finger extending from an end of the funnel.
  • the finger extends generally longitudinally.
  • the finger may extend generally in a spiral.
  • the finger extends from an outlet end of the funnel.
  • the system comprises four fingers spaced-apart around the circumference of the funnel. The fingers are preferably equi-spaced apart.
  • the means to collapse comprises one or more fluid jets for directing a jet of fluid over the medical device.
  • the means to control the wrap may comprise one or more fluid jets for directing a jet of fluid over the medical device.
  • the invention provides in a further aspect a method of loading a medical device into a catheter, the method comprising the steps of:
  • the method may comprise the step of sealing the catheter with flushing liquid therein.
  • a method of delivering a medical device to a desired location in a vasculature comprising the steps of:
  • the method comprises the step of monitoring the extent to which the collapsed medical device has been flushed.
  • the flushing step is terminated when the collapsed medical device has been fully flushed.
  • the liquid may be flushed distally through the catheter.
  • the liquid may be flushed proximally through the catheter.
  • the liquid is flushed through the catheter by creating a pressure differential across the collapsed medical device.
  • the invention provides a catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein, a wall of the catheter around the reception space having flushing openings through the wall to facilitate flushing of a collapsed medical device in the reception space.
  • the concentration of the flushing openings may increase distally along the reception space.
  • the concentration of the flushing openings may increase proximally along the reception space.
  • the concentration of the flushing openings may increase from a centre of the reception space towards proximal and distal ends of the reception space.
  • the catheter preferably comprises means to indicate the extent of flushing of the reception space.
  • the means to indicate comprises one or more perfusion openings in the catheter wall at an end of the reception space.
  • the means to indicate may be provided by a separate component.
  • the means to indicate is provided by a stylet extendable through the catheter.
  • the means to indicate comprises an element configured to change colour upon contact with a flushing liquid.
  • the element comprises litmus.
  • the catheter comprises a seal for sealing the reception space with a collapsed medical device and flushing liquid therein.
  • the seal may extend along substantially the full length of the catheter.
  • the invention provides in another aspect a catheter assembly comprising a catheter of the invention and a collapsible medical device receivable in the reception space of the catheter, the medical device having one or more flushing openings in a body of the medical device to facilitate flushing of the medical device when collapsed in the reception space.
  • the medical device body comprises a coiled spring.
  • a catheter assembly comprising:
  • a catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein;
  • [0078] means for reinforcing against creep a wall of the catheter around the reception space.
  • the means for reinforcing reinforce the catheter wall against longitudinal creep. In another case the means for reinforcing reinforce the catheter wall against radial creep.
  • the means for reinforcing comprises a clamp for positioning around the catheter wall.
  • the clamp may comprise a sleeve.
  • the assembly comprises a tray for the catheter, and the clamp is provided by the tray.
  • the clamp is configured to provide non-uniform reinforcement along the catheter wall.
  • the clamp comprises one or more formations to provide non-uniform reinforcement along the catheter wall.
  • the means for reinforcing comprises one or more reinforcing elements in the catheter wall.
  • the catheter wall is of a composite construction.
  • the invention provides a catheter assembly comprising:
  • a catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein;
  • the means for elongating may comprise a tensioning wire attachable to a medical device.
  • the invention provides in another aspect a method of loading a medical device into a catheter, the method comprising the steps of:
  • the pressure is preferably applied longitudinally.
  • the pressure may be applied radially.
  • the applied pressure is substantially constant over time. In another case the applied pressure varies over time. Ideally the applied pressure varies cyclically over time.
  • a catheter assembly comprising:
  • a catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein;
  • [0097] means for applying pressure to a wall of the catheter around the reception space and/or to a collapsed medical device received in the reception space to distribute loading stresses in the catheter wall and/or the collapsed medical device.
  • FIG. 1 is a side, partially cross sectional view of an embolic protection filter
  • FIGS. 2 ( a ) to 2 ( c ) are schematic views illustrating the coating of the filter with an adhesion preventing material
  • FIGS. 2 ( d ) and 2 ( e ) are schematic views illustrating the loading of the filter into a delivery catheter
  • FIG. 2( f ) is a schematic view of the filter loaded into a delivery catheter in a hoop mounted in a sterile pouch with an enlarged detail of a distal end of the delivery catheter with the filter in place;
  • FIG. 2( g ) and 2 ( h ) are schematic views illustrating the removal of the hoop from the pouch
  • FIGS. 2 ( i ) and 2 ( j ) are schematic views illustrating the removal of the delivery catheter from the hoop
  • FIG. 2( k ) is a schematic view illustrating the flushing of the delivery catheter
  • FIGS. 2 ( l ) to 2 ( n ) are schematic views illustrating the loading of the delivery catheter onto a pre-deployed guidewire
  • FIG. 3 is a schematic view illustrating the loading of a delivery catheter in an arrangement in which a guidewire extends through the delivery catheter prior to entry into the vasculature;
  • FIG. 4 is a cross sectional view of the filter in the collapsed loaded configuration of 2 ( e );
  • FIG. 5 is a cross sectional view of an alternative filter in the collapsed loaded configuration
  • FIG. 6 is an enlarged cross sectional view showing the region between adjacent parts of the filter body in the collapsed configuration
  • FIG. 7 to 16 are enlarged cross-sectional views illustrating the interaction of various adhesion prevention materials with hydrophilic coatings in various arrangements
  • FIG. 17 is a schematic view illustrating an alternative method for coating a filter with an adhesion preventing material
  • FIG. 18 is a schematic view illustrating an alternative method of loading a filter into a delivery catheter
  • FIG. 19 is an end view of another embolic protection filter loaded into a catheter
  • FIG. 20 is an enlarged view of portion of another filter
  • FIGS. 21 is an enlarged perspective view of part of another filter according to the invention.
  • FIGS. 22 and 24 are cross-sectional, side views of a funnel according to the invention.
  • FIG. 23 is an enlarged cross-sectional, end view of a filter passing through the funnel of FIGS. 22 and 23;
  • FIG. 25 is an enlarged view along line XXV-XXV in FIG. 23;
  • FIG. 26 is a schematic, side view illustrating loading of a medical device into a catheter
  • FIG. 27 is a side, cross-sectional view of a catheter according to the invention.
  • FIG. 28 is a schematic representation of 1/porosity along a part of the catheter of FIG. 27;
  • FIG. 29 is a side, cross-sectional view of another catheter according to the invention.
  • FIG. 30 is a schematic representation of 1/porosity along a part of the catheter of FIG. 29;
  • FIG. 31 is a side, cross-sectional view of a further catheter according to the invention.
  • FIG. 32 is a schematic representation of 1/porosity along a part of the catheter of FIG. 31;
  • FIGS. 33 and 35 to 38 are schematic views of a catheter according to the invention, in use;
  • FIGS. 34 and 39 to 40 are schematic views of another catheter according to the invention, in use.
  • FIGS. 41 and 42 are side, cross-sectional views of further catheters according to the invention, in use;
  • FIGS. 43 to 45 are side, partially cross-sectional views of medical devices according to the invention.
  • FIG. 46 is a schematic view of a loaded catheter according to the invention.
  • FIG. 47 is an enlarged, schematic view of the loaded catheter of FIG. 46;
  • FIG. 48 is a plan view of another loaded catheter according to the invention.
  • FIG. 49 is a schematic view of a further loaded catheter according to the invention.
  • FIG. 50 is a partially cross-sectional, side view of a catheter assembly according to the invention.
  • FIG. 51 is a partially cross-sectional, side view of another catheter assembly according to the invention.
  • FIG. 52 is a partially cross-sectional, side view of a further catheter assembly according to the invention on a tray;
  • FIG. 53 is a partially cross-sectional, side view of another catheter assembly according to the invention.
  • FIGS. 54 and 56 are side views of another catheter assembly according to the invention in use.
  • FIGS. 55 and 57 are side views of a further catheter assembly according to the invention in use.
  • FIG. 58 is a partially cross-sectional, side view of another catheter assembly according to the invention.
  • FIG. 59 is a side view of a medical device according to the invention.
  • FIG. 60 is a cross-sectional, side view of the medical device of FIG. 59 loaded into a catheter.
  • an embolic protection filter 1 which in this case comprises a collapsible filter body 2 and a filter support 3 for the filter body 2 .
  • the filter body 2 is located externally of the filter support 3 .
  • the filter support 3 is mounted around an inner tube 8 .
  • the inner tube 8 has a guidewire lumen 12 therethrough, through which a guidewire may pass for exchange of the filter 1 over the guidewire.
  • the filter body 2 has an inlet end 4 and an outlet end 5 .
  • the inlet end 4 has one or more, and in this case two, large inlet openings 6 which are sized to allow blood and embolic material enter the filter body 2 .
  • the outlet end 5 has a plurality of small outlet openings 7 which are sized to allow through passage of blood but to retain undesired embolic material within the filter body 2 .
  • the filter 1 captures and safely retains any undesired embolic material in the blood stream within the filter body 2 while facilitating continued flow of blood through the vascular system. Emboli are thus prevented from flowing further downstream through the vascular system, which could otherwise have potentially catastrophic results.
  • the filter 1 is movable between a low profile, collapsed configuration (FIG. 2 ( e )) for transport through a vasculature, and an expanded configuration (FIG. 1) for deployment in the vasculature.
  • a low profile, collapsed configuration FIG. 2 ( e )
  • an expanded configuration FIG. 1
  • the filter body 2 is supported in the expanded configuration by the filter support 3 so as to maximise the internal volume of the filter body 2 to capture and safely retain as much embolic material as possible.
  • the filter body 2 may be of an oriented polymeric material, as described in International Patent Application No. PCT/IE01/00087 (U.S. Ser. No. 09/887,893), the relevant contents of which are incorporated herein by reference
  • the filter 1 may have a coating of a biocompatible material, in this case a hydrophilic material, around the external surface of the filter body 2 and around the internal surface of the filter body 2 .
  • a biocompatible material in this case a hydrophilic material
  • Fluid mechanics dictates that blood flowing through a pore or series of pores is subjected to shearing forces.
  • Filtration devices are by their nature shearing devices. Excessive shearing forces can causes the activation of platelets which can cause the formation of thrombus. Activated platelets adhere to surfaces and attract more platelets to the site. Passing platelets stick to those already at the site and this leads to a cascade. Fibrin deposition is also a consequence and can form an insoluble threadlike mesh on the filter membrane. Fibrin formation on the filter is undesirable. It may have embolic potential if it enters the blood stream. It may also act to block filter pores reducing the blood flow through the filter and causing localised high shear zones in the remaining open holes.
  • Biocompatible coatings or surfaces are often used to prevent thrombus and fibrin formation on a filter.
  • Biocompatible coatings with hydrophilic properties aid biocompatibility by providing a non-thrombogenic and non-stick surface.
  • the fluid membrane interactions resulting from the activation of the hydrophilic surface layer allows the device to resist fibrin build-up and minimise the risk of clots forming in the blood stream.
  • the interactive surface layer being of a liquid form could typically contain silicone, lipids, heparin or the like.
  • FIG. 5 illustrates a similar arrangement to FIG. 4 but with no longitudinal support/frame shown.
  • an adhesion preventing material 9 such as a silicon fluid, or a silicon gel, or an aqueous material, is applied to the external surface of the filter body 2 and to the internal surface of the filter body 2 prior to loading the filter 1 into a delivery catheter 20 .
  • the adhesion preventing material 9 may be applied in any convenient manner such as by dipping the filter 1 into a bath 15 of the adhesion preventer 9 as illustrated in FIGS. 2 ( a ) to 2 ( c ).
  • the adhesion preventing material 9 provides a means of spacing adjacent folds of the filter body 2 apart. Any hydrophilic coating on one fold of the filter body 2 is thus prevented from adhering to an adjacent fold of the filter body 2 , even when the filter body 2 is tightly wrapped down in the collapsed configuration.
  • the delivery catheter 20 may comprise an outer catheter shaft with an expansible pod at a distal end of the outer catheter shaft, and an inner catheter shaft extending through the outer catheter shaft.
  • the pod extends distally of the inner shaft to facilitate reception of the collapsed filter 1 within the pod.
  • the inner shaft is movable distally relative to the outer shaft to deploy the filter 1 out of the pod.
  • the delivery catheter may be similar to that described in our International Patent Applications Nos. PCT/IE98/00093 (U.S. Ser. No. 09/188,472), PCT/IE01/00052 (U.S. Ser. No. 09/838,544) and PCT/IE01/00053 (U.S. Ser. No. 09/838,545), the relevant contents of which are incorporated herein by reference.
  • the filter 1 is then collapsed and loaded into the delivery catheter 20 (FIG. 2( e )).
  • a funnel may be used to assist collapse of the filter 1 during loading into the delivery catheter 20 .
  • the delivery catheter 20 with the filter 1 loaded in a collapsed configuration may be threaded through a hoop 30 which in turn is packaged aseptically in a sterile pouch 35 (FIG. 2( f )) having a backing sheet 36 and a cover sheet 37 with a pull tab 38 for opening the pouch as illustrated in FIG. 2( g ).
  • the hoop 30 containing the delivery catheter can then be removed as illustrated in FIG. 2( h ).
  • the delivery catheter 20 is removed from the hoop as illustrated in FIG. 2( i ) and 20 ).
  • the removed delivery catheter 20 may then be flushed using a saline injector 40 (FIG. 2( k )).
  • the filter and delivery catheter may be pre-flushed prior to packaging.
  • the delivery catheter 20 with the filter at the distal end thereof may be threaded over the proximal end of a guidewire which has been deployed in the vasculature of a patient.
  • the delivery system may comprise a delivery catheter 46 with a guidewire 47 extending therethrough to which a filter is connected and the delivery system is led through the vasculature Via a guide catheter, sheath or catheter.
  • the loaded delivery catheter 20 is advanced through the vasculature to deliver the collapsed filter 1 to a desired site in the vasculature.
  • the site of deployment of the filter 1 in the vasculature is typically downstream of a treatment site, such as a region of stenosis in the vasculature.
  • the filter 1 is deployed out of the delivery catheter 20 at the desired site in the vasculature.
  • the filter support 3 expands radially outwardly to support the filter body 2 in tubular apposition with the interior wall of the vasculature.
  • the filter 1 captures and safely retains any embolic material in the blood stream within the filter body 2 .
  • the filter 1 is collapsed down and retrieved into a retrieval catheter with any retained embolic material within the filter body 2 .
  • the retrieval catheter is then withdrawn from the vasculature with the filter 1 within the retrieval catheter.
  • the delivery, deployment and retrieval of the embolic protection filter of the invention is similar to that described in our International Patent Applications Nos. PCT/IE98/00093 (U.S. Ser. No. 09/188,472), PCT/IE01/00052 (U.S. Ser. No. 09/838,544) and PCT/IE01/00053 (U.S. Ser. No. 09/838,545), the relevant contents of which are incorporated herein by reference.
  • the filter 1 may be slidably exchanged over the guidewire without any attachment means between the filter 1 and the guidewire. A distal stop on the guidewire assists in retrieval of the filter 1 .
  • the guidewire may remain in the vasculature after retrieval of the filter 1 .
  • hydrophilic coating material 50 on adjacent parts of the filter membrane 51 when folded are illustrated by wavy lines.
  • molecules of the adhesion prevention material 9 are interspersed between the coating 50 , thus preventing the coating 50 from adjacent membranes interacting and becoming attached.
  • FIGS. 7 to 9 illustrate the interaction of the molecules of the hydrophilic coatings 50 of adjacent filter membrane layers when water is excluded or included.
  • FIG. 8 describes two non-contacting hydrophilically coated surfaces. In the case where these two coatings are brought into intimate contact in the presence of water the hydrophilic chains become entangled and adhered as shown in FIG. 9. This may be the case with a wrapped down filter membrane (intimate pressurised contact) which sees moisture (sterilisation or atmospheric exposure). This may hinder/prevent filter deployment from a sheath in the vasculature.
  • FIG. 7 describes two hydrophilically activated (water present) surfaces which are in relatively close contact. Removing the activation reagent (water) from the hydrophilic surfaces and compressing results in the coated surfaces becoming stuck together.
  • FIGS. 10 and 11 illustrate the reversible activation/de-activation of the hydrophilic properties of the surface with the addition/removal of water.
  • FIG. 10 shows the nonactivated case.
  • FIG. 11 shows an activated hydrophilic surface with a swollen and lubricious configuration.
  • FIG. 12 schematically illustrates the use of an adhesion prevention material 9 of relatively large molecular weight such as a high viscosity silicone fluid with a viscosity in the region of 5,000 10,000 centipoise.
  • FIG. 13 schematically illustrates the use of an adhesion prevention material 9 of relatively low molecular weight such as a low viscosity silicone fluid with a viscosity in the region of 1-100 centipoise.
  • adhesion prevention materials can be processed in such a way as to tailor the required molecular weight.
  • adhesion preventers are silicone fluids, PDMS (poly dimethyl siloxane), PEO (polyethylene oxide), PEG (polyethylene glycol), PPO(polypropylene oxide), PPG(polypropylene glycol), lipophilic fluids, hydrophilic fluids, co-polymers of PDMS and PEO and/or PPO and surfactants.
  • adhesion preventers are silicone fluids and aqueous solutions.
  • FIG. 14 illustrates the use of the adhesion prevention material 9 to prevent sticking of the hydrophilic coatings on adjacent filter membrane portions when folded into the collapsed configuration even when the hydrophilic is activated.
  • This shows the case where the hydrophilically coated surfaces with adhesion preventer of FIG. 6 are in pressurised contact and have been activated with water.
  • the adhesion preventer is dispersed between the activated hydrophilic chains and prevents the coatings sticking together even though they are in intimate contact.
  • the adhesion preventer does not evaporate from the system and retains its ability to prevent the molecular interaction (such as van der Waal's forces) of neighbouring hydrophilic chains.
  • the adhesion preventer acts to enable successful deployment of the pre-loaded filter in the vasculature.
  • FIGS. 15 and 16 schematically illustrate the benefits of using a hydrophilic coating in blood contacting applications. Most thrombogenic coatings are also hydrophilic.
  • FIG. 16 illustrates the base membrane 51 without a hydrophilic surface. When blood contacting, this non-hydrophilically coated membrane 51 is not a very passive surface. Cells and/or biological material 55 may adhere to the surface and cause a cascade of fibrin/clot build-up.
  • FIG. 15 shows the membrane 51 with a hydrophilic coating activated with water 56 . This is now extremely lubricious with a high water content. Due to this high water content hydrophilic cellular and biological material adhesion and cascade is minimised.
  • FIG. 17 illustrates another method of applying an adhesion prevention material 9 prior to loading into a delivery catheter.
  • adhesion preventing material 9 may be applied to the external surface of the filter body 2 and to the internal surface of the filter body 2 during collapse and loading of the filter 1 into the delivery catheter 20 , as illustrated in FIG. 18.
  • FIG. 19 there is illustrated another embolic protection filter 60 according to the invention, which is similar to the filter 1 described above, and similar elements in FIG. 9 are assigned the same reference numerals.
  • the filter support 3 comprises a plurality of arms 63 Are these shown which are configured to extend between adjacent folds of the filter body 2 as the filter 60 is collapsed down and loaded into the delivery catheter pod 22 .
  • the filter support 3 provides the means of spacing adjacent folds of the filter body 2 apart, and so the hydrophilic coating on one fold of the filter body 2 is prevented from adhering to an adjacent fold of the filter body 2 , even when the filter 60 is stored in a collapsed configuration within the pod 22 for a relatively long period of time.
  • the surface properties of the filter support 3 and/or the filter body 2 may be configured to minimise the possibility of adhering to one another. Furthermore, the surface formations on the filter support 3 and/or on the filter body 2 may be configured to minimise the possibility of adhering to one another, as illustrated in FIG. 20.
  • the filter body 71 comprises a storage space in the wall 72 of the filter body 71 for storing a biocompatible material, such as a hydrophilic material, in the wall 72 of the filter body 71 during transport through a vasculature.
  • a biocompatible material such as a hydrophilic material
  • the filter 70 may be collapsed down without the risk of one fold of the filter body 2 adhering to an adjacent fold of the filter body 2 .
  • the filter 70 can thus be collapsed down and loaded into a delivery catheter for a relatively long period of time while ensuring that the filter 70 will expand fully radially outwardly when deployed in a vasculature.
  • the filter body 2 comprises a plurality of capillary channels 75 from the storage space in the wall 72 of the filter body 2 to the external surface 73 of the filter body 2 and to the internal surface 74 of the filter body 2 .
  • the channels 75 provide a means of delivering the hydrophilic material from the storage space in the wall 72 to the external and internal surfaces 73 , 74 when the filter 70 is deployed in a vasculature.
  • FIGS. 22 to 25 there is illustrated a system according to the invention for loading a medical device, such as the embolic protection filter 1 described previously, into a catheter, such as the delivery catheter 20 described previously.
  • the system comprises a funnel 80 through which the filter 1 may be passed to collapse the filter 1 down to a wrapped configuration.
  • Four inwardly protruding formations 81 are provided on the wall of the funnel 80 .
  • the protruding formations 81 extend longitudinally from an outlet end 82 of the funnel 80 in the form of four elongate fingers, and the formations 81 are equi-spaced around the circumference of the funnel 80 .
  • the protruding formations 81 control the wrapping down of the filter 1 as the filter 1 is passed through the funnel 80 to collapse the filter 1 .
  • the funnel 80 is mounted to the distal end of the pod 22 of the delivery catheter 20 (FIG. 22).
  • the filter 1 is then passed through the funnel 80 to collapse the filter 1 down to the wrapped configuration.
  • FIG. 23 when the filter 1 enters the funnel 80 at the inlet end 83 of the funnel 80 , the filter 1 is in the expanded configuration.
  • the filter 1 exits the funnel 80 at the outlet end 82 , the filter 1 is collapsed down in the wrapped configuration, as illustrated in FIGS. 24 and 25.
  • the protruding formations 81 engage the filter body 2 and thereby control the wrap of the filter 1 .
  • a more uniform collapsed configuration may be achieved.
  • one or more fluid jets 90 may be provided to direct a jet of fluid, such as air or a hydrophilic fluid, over the filter 1 to collapse the filter 1 down to the wrapped configuration, as illustrated in FIG. 26.
  • a jet of fluid such as air or a hydrophilic fluid
  • the wrap of the filter 1 may also be controlled by the jet of fluid passing over the filter 1 .
  • the catheter 100 comprises a catheter shaft 101 with an expandable pod 102 mounted to the distal end of the shaft 101 .
  • the pod 102 defines a reception space 104 suitable for receiving a collapsed medical device, such as an embolic protection filter, therein.
  • the catheter 100 may be configured for use as a delivery catheter to transport an embolic protection filter through a vasculature to a desired location in the vasculature downstream of a treatment site.
  • the wall of the pod 102 around the reception space 104 has a plurality of flushing openings 103 through the pod wall and evenly spaced along the pod 102 .
  • the provision of these flushing openings 103 in the pod wall enables the filter to be effectively flushed of all air bubbles, while the collapsed filter is positioned within the reception space 104 , without the risk of the pressure of the flushing liquid disturbing or forcing the collapsed filter out of the reception space 104 .
  • the catheter of the invention enables a filter to be loaded into the pod, and then stored in this pre-loaded arrangement until required for use.
  • the clinician may then flush the pre-loaded filter within the pod to ensure all air bubbles are removed from the filter and the pod.
  • the catheter of the invention also enables a filter to be loaded into the pod, completely flushed of air bubbles while in the pod at the site of loading, and then stored in this pre-loaded, pre-flushed arrangement until required for use. In this case, it is not necessary for a clinician to load the filter into the pod, or to flush the filter at all before introducing the catheter into a vasculature.
  • the concentration of the flushing openings 103 increases distally along the pod 102 .
  • This layout of flushing openings 103 results in 1/porosity decreasing distally along the pod 102 , as illustrated in FIG. 30.
  • the concentration of the flushing openings 103 may alternatively increase proximally along the pod 102 .
  • the concentration of the flushing openings 103 increases from a centre of the pod 102 towards the proximal and distal ends of the pod 102 .
  • This layout of flushing openings 103 results in 1/porosity peaking at the centre of the pod 102 and falling off towards the proximal and distal ends of the pod 102 , as illustrated in FIG. 32.
  • FIG. 33 there is illustrated another medical catheter 110 according to the invention, which is similar to the catheter 100 of FIG. 27, and similar elements in FIG. 33 are assigned the same reference numerals.
  • the catheter 110 comprises three perfusion openings 111 in the wall of the pod 102 at the proximal end of the pod 102 (FIG. 33). It will be understood that any suitable number of perfusion openings may be provided in the catheter 110 .???? FIG. 34 description. Replace existing FIG. 34 with FIG. 20 from page 35/59 sent Jan. 5, 2003.
  • a medical device such as the embolic protection filter 1 described previously may be collapsed down and positioned within the reception space 104 at the site of loading.
  • a sealing package around the catheter 110 which is held within a holding tube 113 , is opened as described above.
  • a flushing liquid may be introduced into the reception space 104 at the distal end of the pod 102 , and the catheter 110 and the collapsed filter 1 are flushed proximally, for example by using a syringe 112 while the catheter 110 remains within a holding tube 113 , as illustrated in FIGS. 35 and 35 a.
  • the perfusion openings 111 provide a means of indicating the extent to which the reception space 104 and the collapsed filter 1 have been flushed. By monitoring this extent, the clinician will know when the collapsed filter 1 has been safely flushed of all air bubbles.
  • the syringe 112 is removed from the catheter 110 .
  • the catheter 110 may then be quickly and easily removed from the catheter holding tube 113 .
  • the catheter 110 may be threaded over a guidewire 280 , and advanced over the guidewire 280 through a vasculature to a desired site in the vasculature, such as downstream of a stenosed region of the vasculature.
  • the guidewire 280 has a distal stop 281 at the distal end of the guidewire 280 .
  • the catheter 110 may also be advanced over a standard medical guidewire 290 without any stop formation at the distal end of the guidewire 290 , as illustrated in FIG. 37.
  • the catheter may be advanced through the vasculature at the same time as the guidewire 300 is advanced through the vasculature, as illustrated in FIG. 38. This may arise in the circumstance in which the filter is constrained relative to the guidewire 300 .
  • flushing liquid may alternatively be introduced into the catheter 110 at the proximal end of the shaft 101 , so that the catheter 110 and the collapsed filter 1 are flushed distally.
  • a seal 116 may be releasably mounted at the distal end of the pod 102 after positioning the collapsed filter 1 in the reception space 104 .
  • the catheter 110 and the collapsed filter 1 are then flushed distally using the syringe 112 , as illustrated in FIG. 39.
  • the flushing liquid When the flushing liquid has fully flushed the collapsed filter 1 , the liquid engages against the seal 116 which reverses the flow of the flushing liquid. Some of the flushing liquid then flows proximally to the proximal end of the pod 102 , where the flushing liquid perfuses out through the openings 111 .
  • flushing liquid On initial distal flow of the flushing liquid, it is easiest for the flushing liquid to pass through the filter.
  • the flushing liquid follows the path of least resistance which can be directed by altering the number and size of the openings 111 . As pressure then builds up the flushing liquid exits through the openings 111 .
  • the flushing step is terminated.
  • the catheter 110 may then be quickly and easily removed from the catheter holding tube 113 for introduction into a vasculature of a patient.
  • the catheter 110 may be removed from the holding tube 113 before flushing the collapsed filter 1 and the reception space 104 (FIG. 39).
  • the collapsed filter 1 and the reception space 104 may alternatively be flushed with a flushing liquid 311 at the site of loading (FIG. 40) before the catheter 110 is sealed within the package.
  • the clinician simply needs to remove the holding tube 113 from the package, and remove the catheter 110 from the tube 113 .
  • the catheter 110 is then ready for introduction into a vasculature. In particular it is not necessary for the clinician to flush the catheter 110 at the site of use.
  • a sealing member 310 may be inserted into the filter 1 from the distal end of the filter during the flushing step.
  • the means to indicate the extent of flushing of the reception space of the pod and the collapsed filter 1 could alternatively be provided by a component separate from the catheter.
  • FIG. 41 there is illustrated another catheter 120 according to the invention, which is similar to the catheter 110 of FIG. 33, and similar elements in FIG. 41 are assigned the same reference numerals.
  • the catheter 120 comprises an exit port 121 at the proximal end of the pod 102 .
  • a stylet 122 is extended through the reception space 104 and threaded through the collapsed filter 1 to exit the reception space 104 through the exit port 121 (FIG. 41).
  • the stylet 122 comprises an element 123 which is configured to change colour upon contact with the flushing liquid.
  • a suitable material for the colour change element 123 is litmus.
  • the catheter 120 and the collapsed filter 1 are flushed proximally by introducing the flushing liquid into the reception space 104 at the distal end of the pod 102 using the syringe 124 .
  • the catheter 120 and the collapsed filter 1 could alternatively be flushed distally by introducing the flushing liquid into the catheter 120 at the proximal end of the shaft 100 using the syringe 124 , as illustrated in FIG. 42.
  • the stylet 122 is reversed so that the colour change element 123 is downstream of the collapsed filter 1 .
  • the clinician will be alerted when the collapsed filter 1 has been fully flushed of air bubbles.
  • FIG. 43 there is illustrated another embolic protection filter 130 according to the invention, which is similar to the filter 1 , and similar elements are assigned the same reference numbers.
  • the inner tube 8 of the filter 130 has a series of flushing openings 131 spread longitudinally along the inner tube 8 (FIG. 43). These openings 131 assist in the flushing of air bubbles from the filter 130 when the collapsed filter 130 is positioned in the reception space 104 of a catheter, by distributing the flushing liquid throughout the collapsed filter 130 . Furthermore, the filter 130 may be flushed by introducing the flushing liquid into the guidewire lumen 12 of the inner tube 8 . The flushing liquid then flows out of the guidewire lumen 12 thorough the flushing openings 131 to flush all air bubbles from the collapsed filter 130 .
  • the distribution of the flushing openings 131 along the inner tube 8 may be selectively altered to achieve a thorough flushing of all air bubbles from the collapsed filter 132 .
  • the inner tube is provided in the form of a coiled spring 134 .
  • the spacings between the coils of the spring 134 provide flow pathways for the flushing liquid to pass out of the guidewire lumen 12 to achieve a thorough flushing of all air bubbles from the collapsed filter 133 .
  • FIGS. 46 and 47 illustrate a further catheter 140 according to the invention, which is similar to the catheter 120 of FIGS. 41 and 42, and similar elements in FIGS. 41 and 42 are assigned the same reference numbers.
  • the catheter 140 comprises an inlet port 142 at the proximal end of the pod 102 through which a flushing liquid may be introduced for flushing the reception space 104 and the collapsed filter 1 .
  • the catheter 140 has a seal 141 for sealing around the reception space 104 with the collapsed filter 1 and some of the flushing liquid sealed within the seal 141 .
  • the filter 1 is collapsed down and positioned within the reception space 104 .
  • a source of flushing liquid 143 is then connected in communication with the inlet port 142 , and a vacuum is drawn on the loaded filter 1 to create a pressure differential across the collapsed filter 1 .
  • This vacuum causes the flushing liquid to be drawn through the reception space 104 of the pod 102 and the collapsed filter 1 to dispel all air bubbles from the reception space 104 and the filter 1 .
  • the seal 141 is then applied around the pod 102 with the collapsed filter 1 and some of the flushing liquid sealed within the seal 141 (FIG. 46).
  • the seal 141 in this case, extends proximally over the inlet part 142 (FIG. 47).
  • the sealed catheter 140 may be stored in this arrangement for potentially long periods of time without the risk of any air bubbles entering the reception space 104 or the collapsed filter 1 .
  • the seal 141 is broken.
  • the catheter 140 may then be immediately used to transport the filter 1 through a vasculature without requiring the clinician to flush the reception space 104 or the filter 1 before use.
  • the catheter 140 may be configured for use as a rapid exchange catheter, in which case the flushing inlet port 142 may be used as a guidewire rapid exchange port.
  • FIG. 48 illustrates another catheter 150 according to the invention, which is similar to the catheter 140 of FIGS. 41 and 42.
  • the catheter 150 is an over-the-wire catheter, and the seal 151 extends along the full length of the catheter 150 from the proximal end 152 to the pod 153 .
  • FIG. 49 illustrates a further catheter 250 according to the invention, which is similar to the catheter 140 of FIGS. 41 and 42, and similar elements in FIG. 44 are assigned the same reference numerals.
  • the catheter 250 comprises a plunger 251 at the distal end of the seal 141 .
  • the plunger 251 may be moved proximally through the seal 141 to perform an additional flushing step at the site of use. Continued movement of the plunger proximally increases the pressure within the seal 141 eventually causing the seal 141 to burst.
  • the plunger 251 provides a simple, yet effective means of flushing the collapsed filter 1 and the pod 102 at the site of use, and of bursting open the seal 141 .
  • FIG. 50 there is illustrated a catheter assembly 160 according to the invention.
  • the assembly 160 comprises a catheter 161 and a clamp sleeve 162 .
  • the catheter 161 comprises a catheter shaft 163 with an expansible pod 164 at a distal end of the shaft 163 .
  • the pod 164 defines a reception space 165 for receiving a collapsed medical device, such as the embolic protection filter described previously.
  • the clamp sleeve 162 is releasably mounted to the catheter 161 positioned around the pod 164 .
  • the sleeve 162 reinforces the pod wall against radial creep when the collapsed filter 1 is loaded within the reception space 165 .
  • the filter 1 is collapsed down and positioned within the reception space 165 .
  • the clamp sleeve 162 is then positioned around the pod 164 to reinforce the pod wall against radial creep. In this way the filter 1 may be stored for a relatively long period of time in the collapsed configuration loaded into the catheter without creep of the filter and/or of the pod occurring.
  • the clamp sleeve 162 is demounted from the catheter 161 , and the catheter 161 is introduced into a vasculature to transport the filter 1 to the desired site in the vasculature.
  • FIG. 51 illustrates another catheter assembly 170 according to the invention, which is similar to the catheter assembly 160 of FIG. 45, and similar elements in FIG. 46 are assigned the same reference numerals.
  • the clamp sleeve 162 comprises a plurality of inwardly protruding formations 171 .
  • the formations 171 engage the pod 164 to provide non-uniform reinforcement against radial creep to the pod 164 along the length of the pod 164 .
  • the clamp 181 is provided by a tray 181 for the catheter 161 .
  • the tray 181 has a recess 182 suitably configured to receive the catheter pod 164 when the collapsed filter 1 has been loaded into the reception space 165 .
  • the walls of the tray 181 around the recess 182 then engage against the pod 164 to reinforce against radial creep the pod 164 and the collapsed filter 1 .
  • FIG. 53 there is illustrated another catheter assembly 190 according to the invention, which is similar to the assembly 160 of FIG. 50, and similar elements in FIG. 53 are assigned the same reference numerals.
  • the pod 191 of the catheter 190 has one or more reinforcing elements in the wall of the pod 191 . There elements enhance the radial strength of the pod 191 and provide a means of reinforcing the pod wall against radial creep.
  • the pod may be at least partially of a composite construction for reinforcement against creep.
  • the assembly 200 comprises a tensioning wire 221 releasably attached to the inner tube 8 of the filter 1 .
  • the wire 221 provides a means of elongating the filter 1 to ensure the filter 1 remains fully collapsed when loaded into a catheter reception space (FIG. 54). In this manner, the tensioning wire 221 aids in resisting radial and longitudinal creep of the filter 1 even if the filter 1 is stored for a relatively long period of time loaded in the catheter.
  • the wire 221 also provides a means of accurately holding the filter 1 in position in the pod 22 during storage of the loaded catheter assembly 200 and during advancement of the catheter assembly 200 through a vasculature (FIG. 54).
  • the filter 1 is deployed out of the pod 22 by moving the inner shaft 23 distally relative to the outer shaft 21 (FIG. 56). This relative distal movement of the inner shaft 23 breaks the wire 221 to facilitate deployment of the filter 1 out of the pod 22 .
  • the catheter assembly 260 of FIGS. 55 and 57 is similar to the catheter assembly 200 of FIGS. 56 and 58, and similar elements in FIGS. 55 and 57 are assigned the same reference numerals.
  • the assembly 260 comprises two “I”-shaped connectors 261 extending between the inner shaft 21 of the delivery catheter 20 and the inner tube 8 of the filter 1 .
  • the connectors 261 maintain the position of the filter 1 fixed within the pod 22 during storage of the loaded catheter assembly 260 and during advancement of the catheter assembly 260 through a vasculature (FIG. 55).
  • the inner shaft 23 is moved distally relative to the outer shaft 21 (FIG. 57). This relative distal movement of the inner shaft 23 breaks the connectors 261 to facilitate deployment of the filter 1 out of the pod 22 .
  • Such temporary tethering/connecting may be applied to other systems and the use is not restricted to a preloaded filter arrangement. They may be used in any suitable delivery system, especially those involving delivery over a bare guidewire.
  • FIG. 58 there is illustrated a further catheter assembly 210 according to the invention, which is similar to the assembly 160 of FIG. 50, and similar elements in FIG. 58 are assigned the same reference numerals.
  • the clamp 220 in this case, is in the form of an end-cap releasably mounted over the distal end of the pod 164 .
  • the pressure may be applied in the radial direction F 1 and/or in the longitudinal direction F 2 , and the magnitude of the applied pressure may be varied as desired. In addition, the pressure applied may remain constant over time, or may vary over time, for example in a cyclical manner.
  • FIGS. 59 and 60 there is illustrated a further embolic protection filter 400 according to the invention, which is similar to the filter 1 of FIG. 1, and similar elements in FIGS. 59 and 60 are assigned the same reference numerals.
  • the filter body 2 has a plurality of small outlet openings 401 at the outlet end 5 of the filter 400 and extending along the filter body 2 towards the inlet end 4 , as illustrated in FIG. 59.
  • FIGS. 59 & 60 I think it is important to make reference to the liquid pores and the gas pores.
  • Both the filter and pod may contain both liquid pores and gas pores. Gas pores provide some back pressure and ensure that no air pockets are generated. A gradient of hole sizes might be used to achieve the best flushing.
  • this configuration aids in minimising the possibility of the filter 400 creeping or the pod 22 creeping when the filter 400 is loaded within the pod 22 for periods of time, as illustrated in FIG. 60.

Abstract

An embolic protection system comprises an embolic protection filter 1 having a collapsed delivery configuration and an expanded deployed configuration. The filter 1 is housed in the collapsed configuration in a reception space of a delivery catheter 20. The delivery catheter 20 containing the filter 1 is housed in a sealed sterile pouch 35. The filter 1 may be coated with a non-thrombogenic coating and an adhesion preventer 9 such as a silicon gel is used to substantially prevent adhesion of adjacent folds of the filter 1 when the filter is in the collapsed configuration in the delivery catheter 20.

Description

  • This invention relates to an embolic protection filter, which is movable between a collapsed configuration for transport through a vasculature and an expanded configuration for deployment in a vasculature. [0001]
  • It is known to collapse down and load an embolic protection filter into a delivery catheter. The collapsed filter may then be transported through a vasculature using the delivery catheter until the filter is located at a desired site in the vasculature where the filter may be deployed out of the delivery catheter. [0002]
  • It is also known to coat embolic protection filters with a biocompatible coating to minimise the risk of fibrin build-up on the filter, and the risk of clots forming in the blood stream. [0003]
  • Many of these biocompatible coatings have hydrophilic properties. These hydrophilic coatings interact with water molecules. Water molecules may be absorbed during manufacture, sterilisation, storage or in use. Often the quantity of water absorbed is low leading to the biocompatible coating swelling slightly, and the coating becoming sticky or tacky. [0004]
  • Filter membranes in this state have the potential for self-adherence and this can lead to the collapsed filter becoming stuck to itself in the collapsed configuration with the result that the filter will fail to expand fully, or even expand at all, when deployed in the vasculature. Failure of an embolic protection filter to correctly deploy in a vasculature can potentially lead to embolic material migrating downstream through the vascular system with potentially life-threatening consequences. [0005]
  • Another problem which arises with a low profile filter loaded into a catheter pod is the difficulty in successfully flushing the device to remove any air. Because the filter assumes a packed configuration in the pod it is difficult to remove air from the filter. It may also be easier for the filter to remove itself from the pod due to the flushing pressure in preference to the filter being flushed of air. [0006]
  • This invention is therefore aimed at overcoming at least some of the problems associated with known embolic protection systems. [0007]
  • STATEMENTS OF INVENTION
  • An embolic protection system comprising: [0008]
  • an embolic protection filter having a collapsed delivery configuration and an expanded deployed configuration; [0009]
  • a delivery catheter having a reception space, an embolic protection filter being housed in the collapsed configuration in the reception space of the delivery catheter; and [0010]
  • a sealed sterile pouch housing the delivery catheter containing the filter in the collapsed configuration. [0011]
  • In one embodiment the filter in the collapsed configuration is at least partially folded. [0012]
  • In another embodiment the system comprises an adhesion preventer to substantially prevent adhesion of adjacent folds of the filter to one another in the collapsed configuration. [0013]
  • In a further embodiment the adhesion preventing material is selected from one or more of: [0014]
  • a silicon fluid; [0015]
  • a silicon gel; [0016]
  • a lipid filled fluid/gel; [0017]
  • a heparin filled fluid/gel; and [0018]
  • an aqueous solution. [0019]
  • The invention also provides a medical device movable between a collapsed configuration for transport through a vasculature and an expanded configuration for deployment in a vasculature: [0020]
  • the device having a collapsed configuration in which the device is at least partially folded and an expanded configuration: and [0021]
  • the device comprising an adhesion preventer to prevent adhesion of adjacent folds of the device in the collapsed configuration to one another. [0022]
  • In a preferred embodiment the device comprises a collapsible body and a support structure to support the body in the expanded configuration. The collapsible body may be located at least partially externally of the support structure. The support structure may be located at least partially externally of the collapsible body. [0023]
  • In one embodiment the adhesion preventer comprises means to space adjacent folds of the device apart. Preferably the means to space adjacent folds of the device apart comprises a filler material applied to a surface of the device. The filler material may comprise a silicon fluid, or a silicon gel, or a lipid filled fluid/gel, or a heparin filled fluid/gel, or an aqueous material. [0024]
  • In one case the means to space adjacent folds of the device apart comprises one or more arms for extending between adjacent folds of the device. The support structure may comprise the arm. In a preferred embodiment the arm is provided by a tool which is suitable to assist loading of the device into a catheter. [0025]
  • Preferably the biocompatible surface is provided as a coating of biocompatible material on the device. [0026]
  • The biocompatible surface may be provided on an external surface of the device. [0027]
  • The biocompatible surface may be provided on an internal surface of the device. [0028]
  • According to another aspect the invention provides a method for providing embolic protection during a vascular procedure comprising the steps of: [0029]
  • providing an embolic protection system comprising a sealed sterile pouch containing a delivery catheter with a reception space, an embolic protection filter being housed in the reception space in collapsed configuration; [0030]
  • opening the pouch; and [0031]
  • removing the delivery catheter containing the embolic protection filter in the collapsed configuration from the pouch. [0032]
  • In one embodiment the method comprises the step of flushing the filter in the collapsed configuration within the delivery catheter. [0033]
  • In another embodiment the filter is flushed prior to sealing of the pouch. [0034]
  • In another aspect of the invention, there is provided a medical device movable between a collapsed configuration for transport through a vasculature and an expanded configuration for deployment in a vasculature, the device comprising: [0035]
  • a storage space for storing a biocompatible material during transport through a vasculature; and [0036]
  • means to deliver the biocompatible material from the storage space to a surface of the device when deployed in a vasculature. [0037]
  • The storage space may be provided in a wall of the device. [0038]
  • Preferably the means to deliver the biocompatible material comprises one or more channels from the storage space to the surface of the device. Ideally the channel is a capillary channel. [0039]
  • In one case the biocompatible material is delivered to an external surface of the device. In another case the biocompatible material is delivered to an internal surface of the device. [0040]
  • In a preferred embodiment the device comprises a delivery actuator to at least partially cause delivery of the biocompatible material from the storage space to the surface of the device. Ideally the actuator is at least partially of a temperature memory material. [0041]
  • The biocompatible material may be a hydrophilic material. [0042]
  • In one preferred case the device is an embolic protection filter. Ideally the filter has an inlet end and an outlet end, the inlet end having one or more inlet openings sized to allow blood and embolic material enter the filter, the outlet end having a plurality of outlet openings sized to allow through passage of blood but to retain undesired embolic material within the filter. [0043]
  • In a further aspect, the invention provides a method of loading a medical device into a catheter, the method comprising the steps of: [0044]
  • collapsing the medical device down to a wrapped configuration; [0045]
  • controlling the wrap of the medical device during collapse; and [0046]
  • positioning the medical device at least partially within the catheter. [0047]
  • The medical device may be at least partially collapsed down by passing the medical device through a funnel. Preferably the wrap of the medical device is at least partially controlled by formations on the funnel. [0048]
  • In another embodiment the medical device is at least partially collapsed down by directing a jet of fluid over the medical device. Ideally the wrap of the medical device is at least partially controlled by directing a jet of fluid over the medical device. [0049]
  • Most preferably the medical device is at least partially collapsed during positioning of the medical device at least partially within the catheter. [0050]
  • According to another aspect of the invention, there is provided a system for loading a medical device into a catheter, the system comprising: [0051]
  • means to collapse a medical device down to a wrapped configuration; and [0052]
  • means to control the wrap of the medical device. [0053]
  • In one embodiment the means to collapse comprises a funnel through which a medical device may be passed. Preferably the means to control the wrap comprises one or more formations on the funnel. Ideally the formation comprises an inward protrusion on a wall of the funnel. The protrusion may be in the form of a finger extending from an end of the funnel. Preferably the finger extends generally longitudinally. The finger may extend generally in a spiral. Most preferably the finger extends from an outlet end of the funnel. Ideally the system comprises four fingers spaced-apart around the circumference of the funnel. The fingers are preferably equi-spaced apart. [0054]
  • In another embodiment the means to collapse comprises one or more fluid jets for directing a jet of fluid over the medical device. The means to control the wrap may comprise one or more fluid jets for directing a jet of fluid over the medical device. [0055]
  • The invention provides in a further aspect a method of loading a medical device into a catheter, the method comprising the steps of: [0056]
  • collapsing the medical device; [0057]
  • positioning the collapsed medical device at least partially within the catheter; and [0058]
  • flushing a liquid through the catheter and the collapsed medical device. [0059]
  • The method may comprise the step of sealing the catheter with flushing liquid therein. [0060]
  • In another aspect of the invention, there is provided a method of delivering a medical device to a desired location in a vasculature, the method comprising the steps of: [0061]
  • providing a catheter with a collapsed medical device positioned at least partially within the catheter; [0062]
  • flushing a liquid through the catheter and the collapsed medical device; and [0063]
  • introducing the catheter into a vasculature and advancing the catheter through the vasculature. [0064]
  • Preferably the method comprises the step of monitoring the extent to which the collapsed medical device has been flushed. Ideally the flushing step is terminated when the collapsed medical device has been fully flushed. [0065]
  • The liquid may be flushed distally through the catheter. The liquid may be flushed proximally through the catheter. [0066]
  • Desirably the liquid is flushed through the catheter by creating a pressure differential across the collapsed medical device. [0067]
  • In a further aspect, the invention provides a catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein, a wall of the catheter around the reception space having flushing openings through the wall to facilitate flushing of a collapsed medical device in the reception space. [0068]
  • The concentration of the flushing openings may increase distally along the reception space. The concentration of the flushing openings may increase proximally along the reception space. The concentration of the flushing openings may increase from a centre of the reception space towards proximal and distal ends of the reception space. [0069]
  • The catheter preferably comprises means to indicate the extent of flushing of the reception space. Ideally the means to indicate comprises one or more perfusion openings in the catheter wall at an end of the reception space. [0070]
  • The means to indicate may be provided by a separate component. Preferably the means to indicate is provided by a stylet extendable through the catheter. [0071]
  • In one case the means to indicate comprises an element configured to change colour upon contact with a flushing liquid. Preferably the element comprises litmus. [0072]
  • In a preferred embodiment the catheter comprises a seal for sealing the reception space with a collapsed medical device and flushing liquid therein. The seal may extend along substantially the full length of the catheter. [0073]
  • The invention provides in another aspect a catheter assembly comprising a catheter of the invention and a collapsible medical device receivable in the reception space of the catheter, the medical device having one or more flushing openings in a body of the medical device to facilitate flushing of the medical device when collapsed in the reception space. [0074]
  • Preferably the medical device body comprises a coiled spring. [0075]
  • According to another aspect of the invention, there is provided a catheter assembly comprising: [0076]
  • a catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein; and [0077]
  • means for reinforcing against creep a wall of the catheter around the reception space. [0078]
  • In one case the means for reinforcing reinforce the catheter wall against longitudinal creep. In another case the means for reinforcing reinforce the catheter wall against radial creep. [0079]
  • In a preferred embodiment the means for reinforcing comprises a clamp for positioning around the catheter wall. The clamp may comprise a sleeve. [0080]
  • In another case the assembly comprises a tray for the catheter, and the clamp is provided by the tray. [0081]
  • Ideally the clamp is configured to provide non-uniform reinforcement along the catheter wall. Most preferably the clamp comprises one or more formations to provide non-uniform reinforcement along the catheter wall. [0082]
  • In another embodiment the means for reinforcing comprises one or more reinforcing elements in the catheter wall. Preferably the catheter wall is of a composite construction. [0083]
  • In a further aspect, the invention provides a catheter assembly comprising: [0084]
  • a catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein; and [0085]
  • means for elongating a medical device received in the reception space to resist creeping of the medical device. [0086]
  • The means for elongating may comprise a tensioning wire attachable to a medical device. [0087]
  • The invention provides in another aspect a method of loading a medical device into a catheter, the method comprising the steps of: [0088]
  • collapsing the medical device; [0089]
  • positioning the collapsed medical device at least partially within the catheter; and [0090]
  • applying pressure to the catheter and/or to the collapsed medical device to distribute loading stresses on the catheter and/or on the collapsed medical device. [0091]
  • The pressure is preferably applied longitudinally. [0092]
  • The pressure may be applied radially. [0093]
  • In one case the applied pressure is substantially constant over time. In another case the applied pressure varies over time. Ideally the applied pressure varies cyclically over time. [0094]
  • In a further aspect of the invention, there is provided a catheter assembly comprising: [0095]
  • a catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein; and [0096]
  • means for applying pressure to a wall of the catheter around the reception space and/or to a collapsed medical device received in the reception space to distribute loading stresses in the catheter wall and/or the collapsed medical device.[0097]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will be more clearly understood from the following description of some embodiments thereof, given by way of example only, with reference to the accompanying drawings, in which: [0098]
  • FIG. 1 is a side, partially cross sectional view of an embolic protection filter; [0099]
  • FIGS. [0100] 2(a) to 2(c) are schematic views illustrating the coating of the filter with an adhesion preventing material;
  • FIGS. [0101] 2(d) and 2(e) are schematic views illustrating the loading of the filter into a delivery catheter;
  • FIG. 2([0102] f) is a schematic view of the filter loaded into a delivery catheter in a hoop mounted in a sterile pouch with an enlarged detail of a distal end of the delivery catheter with the filter in place;
  • FIG. 2([0103] g) and 2(h) are schematic views illustrating the removal of the hoop from the pouch;
  • FIGS. [0104] 2(i) and 2(j) are schematic views illustrating the removal of the delivery catheter from the hoop;
  • FIG. 2([0105] k) is a schematic view illustrating the flushing of the delivery catheter;
  • FIGS. [0106] 2(l) to 2(n) are schematic views illustrating the loading of the delivery catheter onto a pre-deployed guidewire;
  • FIG. 3 is a schematic view illustrating the loading of a delivery catheter in an arrangement in which a guidewire extends through the delivery catheter prior to entry into the vasculature; [0107]
  • FIG. 4 is a cross sectional view of the filter in the collapsed loaded configuration of [0108] 2(e);
  • FIG. 5 is a cross sectional view of an alternative filter in the collapsed loaded configuration; [0109]
  • FIG. 6 is an enlarged cross sectional view showing the region between adjacent parts of the filter body in the collapsed configuration; [0110]
  • FIG. 7 to [0111] 16 are enlarged cross-sectional views illustrating the interaction of various adhesion prevention materials with hydrophilic coatings in various arrangements;
  • FIG. 17 is a schematic view illustrating an alternative method for coating a filter with an adhesion preventing material; [0112]
  • FIG. 18 is a schematic view illustrating an alternative method of loading a filter into a delivery catheter; [0113]
  • FIG. 19 is an end view of another embolic protection filter loaded into a catheter; [0114]
  • FIG. 20 is an enlarged view of portion of another filter; [0115]
  • FIGS. [0116] 21 is an enlarged perspective view of part of another filter according to the invention;
  • FIGS. 22 and 24 are cross-sectional, side views of a funnel according to the invention; [0117]
  • FIG. 23 is an enlarged cross-sectional, end view of a filter passing through the funnel of FIGS. 22 and 23; [0118]
  • FIG. 25 is an enlarged view along line XXV-XXV in FIG. 23; [0119]
  • FIG. 26 is a schematic, side view illustrating loading of a medical device into a catheter; [0120]
  • FIG. 27 is a side, cross-sectional view of a catheter according to the invention; [0121]
  • FIG. 28 is a schematic representation of 1/porosity along a part of the catheter of FIG. 27; [0122]
  • FIG. 29 is a side, cross-sectional view of another catheter according to the invention; [0123]
  • FIG. 30 is a schematic representation of 1/porosity along a part of the catheter of FIG. 29; [0124]
  • FIG. 31 is a side, cross-sectional view of a further catheter according to the invention; [0125]
  • FIG. 32 is a schematic representation of 1/porosity along a part of the catheter of FIG. 31; [0126]
  • FIGS. 33 and 35 to [0127] 38 are schematic views of a catheter according to the invention, in use;
  • FIGS. 34 and 39 to [0128] 40 are schematic views of another catheter according to the invention, in use;
  • FIGS. 41 and 42 are side, cross-sectional views of further catheters according to the invention, in use; [0129]
  • FIGS. [0130] 43 to 45 are side, partially cross-sectional views of medical devices according to the invention;
  • FIG. 46 is a schematic view of a loaded catheter according to the invention; [0131]
  • FIG. 47 is an enlarged, schematic view of the loaded catheter of FIG. 46; [0132]
  • FIG. 48 is a plan view of another loaded catheter according to the invention; [0133]
  • FIG. 49 is a schematic view of a further loaded catheter according to the invention; [0134]
  • FIG. 50 is a partially cross-sectional, side view of a catheter assembly according to the invention; [0135]
  • FIG. 51 is a partially cross-sectional, side view of another catheter assembly according to the invention; [0136]
  • FIG. 52 is a partially cross-sectional, side view of a further catheter assembly according to the invention on a tray; [0137]
  • FIG. 53 is a partially cross-sectional, side view of another catheter assembly according to the invention; [0138]
  • FIGS. 54 and 56 are side views of another catheter assembly according to the invention in use; [0139]
  • FIGS. 55 and 57 are side views of a further catheter assembly according to the invention in use; [0140]
  • FIG. 58 is a partially cross-sectional, side view of another catheter assembly according to the invention; [0141]
  • FIG. 59 is a side view of a medical device according to the invention; and [0142]
  • FIG. 60 is a cross-sectional, side view of the medical device of FIG. 59 loaded into a catheter.[0143]
  • DETAILED DESCRIPTION
  • Referring to the drawings and initially to FIG. 1 thereof, there is illustrated an [0144] embolic protection filter 1 which in this case comprises a collapsible filter body 2 and a filter support 3 for the filter body 2. In the embodiment of FIG. 1, the filter body 2 is located externally of the filter support 3. The filter support 3 is mounted around an inner tube 8. The inner tube 8 has a guidewire lumen 12 therethrough, through which a guidewire may pass for exchange of the filter 1 over the guidewire.
  • The [0145] filter body 2 has an inlet end 4 and an outlet end 5. The inlet end 4 has one or more, and in this case two, large inlet openings 6 which are sized to allow blood and embolic material enter the filter body 2. The outlet end 5 has a plurality of small outlet openings 7 which are sized to allow through passage of blood but to retain undesired embolic material within the filter body 2. In this way, the filter 1 captures and safely retains any undesired embolic material in the blood stream within the filter body 2 while facilitating continued flow of blood through the vascular system. Emboli are thus prevented from flowing further downstream through the vascular system, which could otherwise have potentially catastrophic results.
  • The [0146] filter 1 is movable between a low profile, collapsed configuration (FIG. 2 (e)) for transport through a vasculature, and an expanded configuration (FIG. 1) for deployment in the vasculature. As particularly illustrated in FIG. 1, in this expanded configuration, the filter body 2 is supported in the expanded configuration by the filter support 3 so as to maximise the internal volume of the filter body 2 to capture and safely retain as much embolic material as possible.
  • The [0147] filter body 2 may be of an oriented polymeric material, as described in International Patent Application No. PCT/IE01/00087 (U.S. Ser. No. 09/887,893), the relevant contents of which are incorporated herein by reference
  • The [0148] filter 1 may have a coating of a biocompatible material, in this case a hydrophilic material, around the external surface of the filter body 2 and around the internal surface of the filter body 2.
  • Fluid mechanics dictates that blood flowing through a pore or series of pores is subjected to shearing forces. Filtration devices are by their nature shearing devices. Excessive shearing forces can causes the activation of platelets which can cause the formation of thrombus. Activated platelets adhere to surfaces and attract more platelets to the site. Passing platelets stick to those already at the site and this leads to a cascade. Fibrin deposition is also a consequence and can form an insoluble threadlike mesh on the filter membrane. Fibrin formation on the filter is undesirable. It may have embolic potential if it enters the blood stream. It may also act to block filter pores reducing the blood flow through the filter and causing localised high shear zones in the remaining open holes. [0149]
  • Biocompatible coatings or surfaces are often used to prevent thrombus and fibrin formation on a filter. Biocompatible coatings with hydrophilic properties aid biocompatibility by providing a non-thrombogenic and non-stick surface. [0150]
  • The fluid membrane interactions resulting from the activation of the hydrophilic surface layer, which is liquid or substantially liquid, allows the device to resist fibrin build-up and minimise the risk of clots forming in the blood stream. The interactive surface layer, being of a liquid form could typically contain silicone, lipids, heparin or the like. [0151]
  • As illustrated in FIG. 4, when the [0152] filter 1 is in the collapsed configuration, the filter body 2 is tightly folded over upon itself. FIG. 5 illustrates a similar arrangement to FIG. 4 but with no longitudinal support/frame shown.
  • To prevent the relatively sticky hydrophilic coating on one fold of the [0153] filter body 2 adhering to an adjacent fold of the filter body 2, an adhesion preventing material 9, such as a silicon fluid, or a silicon gel, or an aqueous material, is applied to the external surface of the filter body 2 and to the internal surface of the filter body 2 prior to loading the filter 1 into a delivery catheter 20.
  • The adhesion preventing material [0154] 9 may be applied in any convenient manner such as by dipping the filter 1 into a bath 15 of the adhesion preventer 9 as illustrated in FIGS. 2(a) to 2(c).
  • As illustrated partially in FIGS. 4 and 5, the adhesion preventing material [0155] 9 provides a means of spacing adjacent folds of the filter body 2 apart. Any hydrophilic coating on one fold of the filter body 2 is thus prevented from adhering to an adjacent fold of the filter body 2, even when the filter body 2 is tightly wrapped down in the collapsed configuration.
  • The [0156] delivery catheter 20 may comprise an outer catheter shaft with an expansible pod at a distal end of the outer catheter shaft, and an inner catheter shaft extending through the outer catheter shaft. In the delivery configuration illustrated, the pod extends distally of the inner shaft to facilitate reception of the collapsed filter 1 within the pod. The inner shaft is movable distally relative to the outer shaft to deploy the filter 1 out of the pod.
  • The delivery catheter may be similar to that described in our International Patent Applications Nos. PCT/IE98/00093 (U.S. Ser. No. 09/188,472), PCT/IE01/00052 (U.S. Ser. No. 09/838,544) and PCT/IE01/00053 (U.S. Ser. No. 09/838,545), the relevant contents of which are incorporated herein by reference. [0157]
  • In use, when the adhesion preventing material [0158] 9 has been applied to the filter body 2 (FIG. 2(d)), the filter 1 is then collapsed and loaded into the delivery catheter 20 (FIG. 2(e)). A funnel may be used to assist collapse of the filter 1 during loading into the delivery catheter 20.
  • The [0159] delivery catheter 20 with the filter 1 loaded in a collapsed configuration may be threaded through a hoop 30 which in turn is packaged aseptically in a sterile pouch 35 (FIG. 2(f)) having a backing sheet 36 and a cover sheet 37 with a pull tab 38 for opening the pouch as illustrated in FIG. 2(g). The hoop 30 containing the delivery catheter can then be removed as illustrated in FIG. 2(h). The delivery catheter 20 is removed from the hoop as illustrated in FIG. 2(i) and 20). The removed delivery catheter 20 may then be flushed using a saline injector 40 (FIG. 2(k)). Alternatively or additionally the filter and delivery catheter may be pre-flushed prior to packaging.
  • In the arrangements illustrated in FIGS. [0160] 2(e) to 2(n) the delivery catheter 20 with the filter at the distal end thereof may be threaded over the proximal end of a guidewire which has been deployed in the vasculature of a patient. Alternatively, as illustrated in FIG. 3 the delivery system may comprise a delivery catheter 46 with a guidewire 47 extending therethrough to which a filter is connected and the delivery system is led through the vasculature Via a guide catheter, sheath or catheter.
  • The loaded [0161] delivery catheter 20 is advanced through the vasculature to deliver the collapsed filter 1 to a desired site in the vasculature. The site of deployment of the filter 1 in the vasculature is typically downstream of a treatment site, such as a region of stenosis in the vasculature.
  • The [0162] filter 1 is deployed out of the delivery catheter 20 at the desired site in the vasculature. The filter support 3 expands radially outwardly to support the filter body 2 in tubular apposition with the interior wall of the vasculature. During the subsequent performance of a treatment procedure, on the vasculature the filter 1 captures and safely retains any embolic material in the blood stream within the filter body 2.
  • After completion of the treatment procedure, the [0163] filter 1 is collapsed down and retrieved into a retrieval catheter with any retained embolic material within the filter body 2. The retrieval catheter is then withdrawn from the vasculature with the filter 1 within the retrieval catheter.
  • The delivery, deployment and retrieval of the embolic protection filter of the invention, as described above, is similar to that described in our International Patent Applications Nos. PCT/IE98/00093 (U.S. Ser. No. 09/188,472), PCT/IE01/00052 (U.S. Ser. No. 09/838,544) and PCT/IE01/00053 (U.S. Ser. No. 09/838,545), the relevant contents of which are incorporated herein by reference. The [0164] filter 1 may be slidably exchanged over the guidewire without any attachment means between the filter 1 and the guidewire. A distal stop on the guidewire assists in retrieval of the filter 1. The guidewire may remain in the vasculature after retrieval of the filter 1.
  • Referring now to FIG. 6, [0165] hydrophilic coating material 50 on adjacent parts of the filter membrane 51, when folded are illustrated by wavy lines. In the invention molecules of the adhesion prevention material 9 are interspersed between the coating 50, thus preventing the coating 50 from adjacent membranes interacting and becoming attached.
  • FIGS. [0166] 7 to 9 illustrate the interaction of the molecules of the hydrophilic coatings 50 of adjacent filter membrane layers when water is excluded or included. FIG. 8 describes two non-contacting hydrophilically coated surfaces. In the case where these two coatings are brought into intimate contact in the presence of water the hydrophilic chains become entangled and adhered as shown in FIG. 9. This may be the case with a wrapped down filter membrane (intimate pressurised contact) which sees moisture (sterilisation or atmospheric exposure). This may hinder/prevent filter deployment from a sheath in the vasculature. FIG. 7 describes two hydrophilically activated (water present) surfaces which are in relatively close contact. Removing the activation reagent (water) from the hydrophilic surfaces and compressing results in the coated surfaces becoming stuck together.
  • FIGS. 10 and 11 illustrate the reversible activation/de-activation of the hydrophilic properties of the surface with the addition/removal of water. FIG. 10 shows the nonactivated case. FIG. 11 shows an activated hydrophilic surface with a swollen and lubricious configuration. [0167]
  • FIG. 12 schematically illustrates the use of an adhesion prevention material [0168] 9 of relatively large molecular weight such as a high viscosity silicone fluid with a viscosity in the region of 5,000 10,000 centipoise.
  • FIG. 13 schematically illustrates the use of an adhesion prevention material [0169] 9 of relatively low molecular weight such as a low viscosity silicone fluid with a viscosity in the region of 1-100 centipoise. In general, adhesion prevention materials can be processed in such a way as to tailor the required molecular weight.
  • Exemplary examples of adhesion preventers are silicone fluids, PDMS (poly dimethyl siloxane), PEO (polyethylene oxide), PEG (polyethylene glycol), PPO(polypropylene oxide), PPG(polypropylene glycol), lipophilic fluids, hydrophilic fluids, co-polymers of PDMS and PEO and/or PPO and surfactants. Examples of low molecular weight adhesion preventers are silicone fluids and aqueous solutions. [0170]
  • FIG. 14 illustrates the use of the adhesion prevention material [0171] 9 to prevent sticking of the hydrophilic coatings on adjacent filter membrane portions when folded into the collapsed configuration even when the hydrophilic is activated. This shows the case where the hydrophilically coated surfaces with adhesion preventer of FIG. 6 are in pressurised contact and have been activated with water. The adhesion preventer is dispersed between the activated hydrophilic chains and prevents the coatings sticking together even though they are in intimate contact. The adhesion preventer does not evaporate from the system and retains its ability to prevent the molecular interaction (such as van der Waal's forces) of neighbouring hydrophilic chains. The adhesion preventer acts to enable successful deployment of the pre-loaded filter in the vasculature.
  • FIGS. 15 and 16 schematically illustrate the benefits of using a hydrophilic coating in blood contacting applications. Most thrombogenic coatings are also hydrophilic. FIG. 16 illustrates the [0172] base membrane 51 without a hydrophilic surface. When blood contacting, this non-hydrophilically coated membrane 51 is not a very passive surface. Cells and/or biological material 55 may adhere to the surface and cause a cascade of fibrin/clot build-up. FIG. 15 shows the membrane 51 with a hydrophilic coating activated with water 56. This is now extremely lubricious with a high water content. Due to this high water content hydrophilic cellular and biological material adhesion and cascade is minimised.
  • FIG. 17 illustrates another method of applying an adhesion prevention material [0173] 9 prior to loading into a delivery catheter.
  • It will be appreciated that the adhesion preventing material [0174] 9 may be applied to the external surface of the filter body 2 and to the internal surface of the filter body 2 during collapse and loading of the filter 1 into the delivery catheter 20, as illustrated in FIG. 18.
  • In FIG. 19, there is illustrated another [0175] embolic protection filter 60 according to the invention, which is similar to the filter 1 described above, and similar elements in FIG. 9 are assigned the same reference numerals. In this case, the filter support 3 comprises a plurality of arms 63 Are these shown which are configured to extend between adjacent folds of the filter body 2 as the filter 60 is collapsed down and loaded into the delivery catheter pod 22. Thus the filter support 3 provides the means of spacing adjacent folds of the filter body 2 apart, and so the hydrophilic coating on one fold of the filter body 2 is prevented from adhering to an adjacent fold of the filter body 2, even when the filter 60 is stored in a collapsed configuration within the pod 22 for a relatively long period of time.
  • The surface properties of the [0176] filter support 3 and/or the filter body 2 may be configured to minimise the possibility of adhering to one another. Furthermore, the surface formations on the filter support 3 and/or on the filter body 2 may be configured to minimise the possibility of adhering to one another, as illustrated in FIG. 20.
  • In FIG. 21, there is illustrated a further [0177] embolic protection filter 70 according to the invention, which is similar to the filter 1 described above. In this case, the filter body 71 comprises a storage space in the wall 72 of the filter body 71 for storing a biocompatible material, such as a hydrophilic material, in the wall 72 of the filter body 71 during transport through a vasculature. By storing the hydrophilic material in the wall 72 of the filter body 71 away from the external surface 73 of the filter body 2 and the internal surface 74 of the filter body 2, the filter 70 may be collapsed down without the risk of one fold of the filter body 2 adhering to an adjacent fold of the filter body 2. The filter 70 can thus be collapsed down and loaded into a delivery catheter for a relatively long period of time while ensuring that the filter 70 will expand fully radially outwardly when deployed in a vasculature.
  • The [0178] filter body 2 comprises a plurality of capillary channels 75 from the storage space in the wall 72 of the filter body 2 to the external surface 73 of the filter body 2 and to the internal surface 74 of the filter body 2. The channels 75 provide a means of delivering the hydrophilic material from the storage space in the wall 72 to the external and internal surfaces 73, 74 when the filter 70 is deployed in a vasculature.
  • Referring to FIGS. [0179] 22 to 25, there is illustrated a system according to the invention for loading a medical device, such as the embolic protection filter 1 described previously, into a catheter, such as the delivery catheter 20 described previously.
  • The system comprises a [0180] funnel 80 through which the filter 1 may be passed to collapse the filter 1 down to a wrapped configuration. Four inwardly protruding formations 81 are provided on the wall of the funnel 80. The protruding formations 81 extend longitudinally from an outlet end 82 of the funnel 80 in the form of four elongate fingers, and the formations 81 are equi-spaced around the circumference of the funnel 80.
  • The protruding [0181] formations 81 control the wrapping down of the filter 1 as the filter 1 is passed through the funnel 80 to collapse the filter 1.
  • In use, the [0182] funnel 80 is mounted to the distal end of the pod 22 of the delivery catheter 20 (FIG. 22). The filter 1 is then passed through the funnel 80 to collapse the filter 1 down to the wrapped configuration. As illustrated in FIG. 23, when the filter 1 enters the funnel 80 at the inlet end 83 of the funnel 80, the filter 1 is in the expanded configuration. When the filter 1 exits the funnel 80 at the outlet end 82, the filter 1 is collapsed down in the wrapped configuration, as illustrated in FIGS. 24 and 25.
  • In addition, as the [0183] filter 1 is passed through the funnel 80, the protruding formations 81 engage the filter body 2 and thereby control the wrap of the filter 1. By thus controlling the wrapping of the filter 1, a more uniform collapsed configuration may be achieved.
  • It will be appreciated that alternative means of collapsing the [0184] filter 1, and/or alternative means of controlling the wrap of the filter 1 may also be employed in addition to or as an alternative to the funnel 80.
  • For example one or more fluid jets [0185] 90 may be provided to direct a jet of fluid, such as air or a hydrophilic fluid, over the filter 1 to collapse the filter 1 down to the wrapped configuration, as illustrated in FIG. 26. By appropriately selecting the pressure of the fluid in each jet 90 the wrap of the filter 1 may also be controlled by the jet of fluid passing over the filter 1.
  • Referring to FIG. 27, there is illustrated a [0186] medical catheter 100 according to the invention. The catheter 100 comprises a catheter shaft 101 with an expandable pod 102 mounted to the distal end of the shaft 101. The pod 102 defines a reception space 104 suitable for receiving a collapsed medical device, such as an embolic protection filter, therein. In this manner, the catheter 100 may be configured for use as a delivery catheter to transport an embolic protection filter through a vasculature to a desired location in the vasculature downstream of a treatment site.
  • The wall of the [0187] pod 102 around the reception space 104 has a plurality of flushing openings 103 through the pod wall and evenly spaced along the pod 102. The provision of these flushing openings 103 in the pod wall enables the filter to be effectively flushed of all air bubbles, while the collapsed filter is positioned within the reception space 104, without the risk of the pressure of the flushing liquid disturbing or forcing the collapsed filter out of the reception space 104.
  • Thus the catheter of the invention enables a filter to be loaded into the pod, and then stored in this pre-loaded arrangement until required for use. When the filter and catheter are subsequently required for use, the clinician may then flush the pre-loaded filter within the pod to ensure all air bubbles are removed from the filter and the pod. [0188]
  • Therefore it is not necessary for the clinician to load the filter into the pod at the site of use. In this case the clinician simply flushes the filter and the pod, and then inserts the catheter into a vasculature. [0189]
  • The catheter of the invention also enables a filter to be loaded into the pod, completely flushed of air bubbles while in the pod at the site of loading, and then stored in this pre-loaded, pre-flushed arrangement until required for use. In this case, it is not necessary for a clinician to load the filter into the pod, or to flush the filter at all before introducing the catheter into a vasculature. [0190]
  • It will be appreciated that by appropriately selecting the size, and/or the layout, and/or the concentration of the flushing [0191] openings 103 along the pod 102, the pressure of the flushing liquid on the collapsed filter in the pod 102 may be controlled.
  • For example, in the [0192] catheter 106 of FIG. 29, the concentration of the flushing openings 103 increases distally along the pod 102. This layout of flushing openings 103 results in 1/porosity decreasing distally along the pod 102, as illustrated in FIG. 30. The concentration of the flushing openings 103 may alternatively increase proximally along the pod 102. As a further alternative, in the catheter 107 of FIG. 31 the concentration of the flushing openings 103 increases from a centre of the pod 102 towards the proximal and distal ends of the pod 102. This layout of flushing openings 103 results in 1/porosity peaking at the centre of the pod 102 and falling off towards the proximal and distal ends of the pod 102, as illustrated in FIG. 32.
  • In FIG. 33, there is illustrated another [0193] medical catheter 110 according to the invention, which is similar to the catheter 100 of FIG. 27, and similar elements in FIG. 33 are assigned the same reference numerals.
  • In this case, the [0194] catheter 110 comprises three perfusion openings 111 in the wall of the pod 102 at the proximal end of the pod 102 (FIG. 33). It will be understood that any suitable number of perfusion openings may be provided in the catheter 110.???? FIG. 34 description. Replace existing FIG. 34 with FIG. 20 from page 35/59 sent Jan. 5, 2003.
  • Referring to FIGS. 35 and 35[0195] a, in use, a medical device such as the embolic protection filter 1 described previously may be collapsed down and positioned within the reception space 104 at the site of loading. When it is subsequently desired to use the catheter 110 and the collapsed filter 1, a sealing package around the catheter 110, which is held within a holding tube 113, is opened as described above. At the site of use, a flushing liquid may be introduced into the reception space 104 at the distal end of the pod 102, and the catheter 110 and the collapsed filter 1 are flushed proximally, for example by using a syringe 112 while the catheter 110 remains within a holding tube 113, as illustrated in FIGS. 35 and 35a.
  • When the flushing liquid is flushed through the [0196] reception space 104 and the collapsed filter 1, some of the flushing liquid will perfuse out through the openings 111 at the proximal end of the pod 102. Once the clinician sees the flushing liquid perfuse out through the openings 111, the clinician can be satisfied that the collapsed filter 1 has been fully flushed of any air bubbles and the flushing step may be terminated.
  • In this manner, the perfusion openings [0197] 111 provide a means of indicating the extent to which the reception space 104 and the collapsed filter 1 have been flushed. By monitoring this extent, the clinician will know when the collapsed filter 1 has been safely flushed of all air bubbles.
  • When the flushing step has been terminated, the [0198] syringe 112 is removed from the catheter 110. The catheter 110 may then be quickly and easily removed from the catheter holding tube 113.
  • In some cases the [0199] catheter 110 may be threaded over a guidewire 280, and advanced over the guidewire 280 through a vasculature to a desired site in the vasculature, such as downstream of a stenosed region of the vasculature.
  • In the case of the [0200] guidewire 280 of FIG. 36, the guidewire 280 has a distal stop 281 at the distal end of the guidewire 280.
  • However the [0201] catheter 110 may also be advanced over a standard medical guidewire 290 without any stop formation at the distal end of the guidewire 290, as illustrated in FIG. 37.
  • As a further alternative, the catheter may be advanced through the vasculature at the same time as the [0202] guidewire 300 is advanced through the vasculature, as illustrated in FIG. 38. This may arise in the circumstance in which the filter is constrained relative to the guidewire 300.
  • It will be appreciated that the flushing liquid may alternatively be introduced into the [0203] catheter 110 at the proximal end of the shaft 101, so that the catheter 110 and the collapsed filter 1 are flushed distally.
  • As illustrated in FIG. 34, a [0204] seal 116 may be releasably mounted at the distal end of the pod 102 after positioning the collapsed filter 1 in the reception space 104. The catheter 110 and the collapsed filter 1 are then flushed distally using the syringe 112, as illustrated in FIG. 39. When the flushing liquid has fully flushed the collapsed filter 1, the liquid engages against the seal 116 which reverses the flow of the flushing liquid. Some of the flushing liquid then flows proximally to the proximal end of the pod 102, where the flushing liquid perfuses out through the openings 111.
  • On initial distal flow of the flushing liquid, it is easiest for the flushing liquid to pass through the filter. The flushing liquid follows the path of least resistance which can be directed by altering the number and size of the openings [0205] 111. As pressure then builds up the flushing liquid exits through the openings 111.
  • When the clinician sees the flushing liquid perfuse out through the openings [0206] 111, the flushing step is terminated. The catheter 110 may then be quickly and easily removed from the catheter holding tube 113 for introduction into a vasculature of a patient.
  • It will further be appreciated that the [0207] catheter 110 may be removed from the holding tube 113 before flushing the collapsed filter 1 and the reception space 104 (FIG. 39). The collapsed filter 1 and the reception space 104 may alternatively be flushed with a flushing liquid 311 at the site of loading (FIG. 40) before the catheter 110 is sealed within the package. When it is subsequently desired to use the catheter 110, the clinician simply needs to remove the holding tube 113 from the package, and remove the catheter 110 from the tube 113. The catheter 110 is then ready for introduction into a vasculature. In particular it is not necessary for the clinician to flush the catheter 110 at the site of use.
  • A sealing member [0208] 310 may be inserted into the filter 1 from the distal end of the filter during the flushing step.
  • The means to indicate the extent of flushing of the reception space of the pod and the [0209] collapsed filter 1 could alternatively be provided by a component separate from the catheter.
  • For example, in FIG. 41 there is illustrated another [0210] catheter 120 according to the invention, which is similar to the catheter 110 of FIG. 33, and similar elements in FIG. 41 are assigned the same reference numerals.
  • The [0211] catheter 120 comprises an exit port 121 at the proximal end of the pod 102. A stylet 122 is extended through the reception space 104 and threaded through the collapsed filter 1 to exit the reception space 104 through the exit port 121 (FIG. 41).
  • The [0212] stylet 122 comprises an element 123 which is configured to change colour upon contact with the flushing liquid. A suitable material for the colour change element 123 is litmus.
  • By monitoring the colour of the [0213] element 123, the clinician will be alerted when the collapsed filter 1 has been fully flushed of air bubbles.
  • In FIG. 41, the [0214] catheter 120 and the collapsed filter 1 are flushed proximally by introducing the flushing liquid into the reception space 104 at the distal end of the pod 102 using the syringe 124.
  • The [0215] catheter 120 and the collapsed filter 1 could alternatively be flushed distally by introducing the flushing liquid into the catheter 120 at the proximal end of the shaft 100 using the syringe 124, as illustrated in FIG. 42. In this case the stylet 122 is reversed so that the colour change element 123 is downstream of the collapsed filter 1. In this way, by monitoring the colour of the element 123, the clinician will be alerted when the collapsed filter 1 has been fully flushed of air bubbles.
  • Referring to FIG. 43, there is illustrated another embolic protection filter [0216] 130 according to the invention, which is similar to the filter 1, and similar elements are assigned the same reference numbers.
  • In this case, the [0217] inner tube 8 of the filter 130 has a series of flushing openings 131 spread longitudinally along the inner tube 8 (FIG. 43). These openings 131 assist in the flushing of air bubbles from the filter 130 when the collapsed filter 130 is positioned in the reception space 104 of a catheter, by distributing the flushing liquid throughout the collapsed filter 130. Furthermore, the filter 130 may be flushed by introducing the flushing liquid into the guidewire lumen 12 of the inner tube 8. The flushing liquid then flows out of the guidewire lumen 12 thorough the flushing openings 131 to flush all air bubbles from the collapsed filter 130.
  • As illustrated in the filter [0218] 132 of FIG. 44, the distribution of the flushing openings 131 along the inner tube 8 may be selectively altered to achieve a thorough flushing of all air bubbles from the collapsed filter 132.
  • In the [0219] filter 133 of FIG. 45, the inner tube is provided in the form of a coiled spring 134. The spacings between the coils of the spring 134 provide flow pathways for the flushing liquid to pass out of the guidewire lumen 12 to achieve a thorough flushing of all air bubbles from the collapsed filter 133.
  • FIGS. 46 and 47 illustrate a [0220] further catheter 140 according to the invention, which is similar to the catheter 120 of FIGS. 41 and 42, and similar elements in FIGS. 41 and 42 are assigned the same reference numbers.
  • The [0221] catheter 140 comprises an inlet port 142 at the proximal end of the pod 102 through which a flushing liquid may be introduced for flushing the reception space 104 and the collapsed filter 1.
  • The [0222] catheter 140 has a seal 141 for sealing around the reception space 104 with the collapsed filter 1 and some of the flushing liquid sealed within the seal 141.
  • In use, the [0223] filter 1 is collapsed down and positioned within the reception space 104. A source of flushing liquid 143 is then connected in communication with the inlet port 142, and a vacuum is drawn on the loaded filter 1 to create a pressure differential across the collapsed filter 1. This vacuum causes the flushing liquid to be drawn through the reception space 104 of the pod 102 and the collapsed filter 1 to dispel all air bubbles from the reception space 104 and the filter 1.
  • The [0224] seal 141 is then applied around the pod 102 with the collapsed filter 1 and some of the flushing liquid sealed within the seal 141 (FIG. 46). The seal 141, in this case, extends proximally over the inlet part 142 (FIG. 47).
  • The sealed [0225] catheter 140 may be stored in this arrangement for potentially long periods of time without the risk of any air bubbles entering the reception space 104 or the collapsed filter 1. When the catheter 140 is required for use, the seal 141 is broken. The catheter 140 may then be immediately used to transport the filter 1 through a vasculature without requiring the clinician to flush the reception space 104 or the filter 1 before use.
  • It will be appreciated that the [0226] catheter 140 may be configured for use as a rapid exchange catheter, in which case the flushing inlet port 142 may be used as a guidewire rapid exchange port.
  • FIG. 48 illustrates another [0227] catheter 150 according to the invention, which is similar to the catheter 140 of FIGS. 41 and 42.
  • The [0228] catheter 150 is an over-the-wire catheter, and the seal 151 extends along the full length of the catheter 150 from the proximal end 152 to the pod 153.
  • FIG. 49 illustrates a [0229] further catheter 250 according to the invention, which is similar to the catheter 140 of FIGS. 41 and 42, and similar elements in FIG. 44 are assigned the same reference numerals.
  • The [0230] catheter 250 comprises a plunger 251 at the distal end of the seal 141.
  • When the clinician is ready to use the [0231] catheter 250, the plunger 251 may be moved proximally through the seal 141 to perform an additional flushing step at the site of use. Continued movement of the plunger proximally increases the pressure within the seal 141 eventually causing the seal 141 to burst. Thus the plunger 251 provides a simple, yet effective means of flushing the collapsed filter 1 and the pod 102 at the site of use, and of bursting open the seal 141.
  • In FIG. 50, there is illustrated a catheter assembly [0232] 160 according to the invention. The assembly 160 comprises a catheter 161 and a clamp sleeve 162.
  • The [0233] catheter 161 comprises a catheter shaft 163 with an expansible pod 164 at a distal end of the shaft 163. The pod 164 defines a reception space 165 for receiving a collapsed medical device, such as the embolic protection filter described previously.
  • The [0234] clamp sleeve 162 is releasably mounted to the catheter 161 positioned around the pod 164. The sleeve 162 reinforces the pod wall against radial creep when the collapsed filter 1 is loaded within the reception space 165.
  • In use, the [0235] filter 1 is collapsed down and positioned within the reception space 165. The clamp sleeve 162 is then positioned around the pod 164 to reinforce the pod wall against radial creep. In this way the filter 1 may be stored for a relatively long period of time in the collapsed configuration loaded into the catheter without creep of the filter and/or of the pod occurring.
  • When the [0236] catheter 161 is required for use, the clamp sleeve 162 is demounted from the catheter 161, and the catheter 161 is introduced into a vasculature to transport the filter 1 to the desired site in the vasculature.
  • FIG. 51 illustrates another [0237] catheter assembly 170 according to the invention, which is similar to the catheter assembly 160 of FIG. 45, and similar elements in FIG. 46 are assigned the same reference numerals.
  • In this case the [0238] clamp sleeve 162 comprises a plurality of inwardly protruding formations 171. The formations 171 engage the pod 164 to provide non-uniform reinforcement against radial creep to the pod 164 along the length of the pod 164.
  • In the case of the catheter assembly [0239] 180 of FIG. 52, the clamp 181 is provided by a tray 181 for the catheter 161. The tray 181 has a recess 182 suitably configured to receive the catheter pod 164 when the collapsed filter 1 has been loaded into the reception space 165. The walls of the tray 181 around the recess 182 then engage against the pod 164 to reinforce against radial creep the pod 164 and the collapsed filter 1.
  • Referring next to FIG. 53, there is illustrated another catheter assembly [0240] 190 according to the invention, which is similar to the assembly 160 of FIG. 50, and similar elements in FIG. 53 are assigned the same reference numerals.
  • The [0241] pod 191 of the catheter 190 has one or more reinforcing elements in the wall of the pod 191. There elements enhance the radial strength of the pod 191 and provide a means of reinforcing the pod wall against radial creep.
  • In another case, the pod may be at least partially of a composite construction for reinforcement against creep. [0242]
  • In the [0243] catheter assembly 200 of FIGS. 54 and 56, the assembly 200 comprises a tensioning wire 221 releasably attached to the inner tube 8 of the filter 1.
  • The [0244] wire 221 provides a means of elongating the filter 1 to ensure the filter 1 remains fully collapsed when loaded into a catheter reception space (FIG. 54). In this manner, the tensioning wire 221 aids in resisting radial and longitudinal creep of the filter 1 even if the filter 1 is stored for a relatively long period of time loaded in the catheter.
  • The [0245] wire 221 also provides a means of accurately holding the filter 1 in position in the pod 22 during storage of the loaded catheter assembly 200 and during advancement of the catheter assembly 200 through a vasculature (FIG. 54).
  • The [0246] filter 1 is deployed out of the pod 22 by moving the inner shaft 23 distally relative to the outer shaft 21 (FIG. 56). This relative distal movement of the inner shaft 23 breaks the wire 221 to facilitate deployment of the filter 1 out of the pod 22.
  • The [0247] catheter assembly 260 of FIGS. 55 and 57 is similar to the catheter assembly 200 of FIGS. 56 and 58, and similar elements in FIGS. 55 and 57 are assigned the same reference numerals.
  • In this case, the [0248] assembly 260 comprises two “I”-shaped connectors 261 extending between the inner shaft 21 of the delivery catheter 20 and the inner tube 8 of the filter 1. The connectors 261 maintain the position of the filter 1 fixed within the pod 22 during storage of the loaded catheter assembly 260 and during advancement of the catheter assembly 260 through a vasculature (FIG. 55).
  • To deploy the filter out of the [0249] pod 22, the inner shaft 23 is moved distally relative to the outer shaft 21 (FIG. 57). This relative distal movement of the inner shaft 23 breaks the connectors 261 to facilitate deployment of the filter 1 out of the pod 22.
  • Such temporary tethering/connecting may be applied to other systems and the use is not restricted to a preloaded filter arrangement. They may be used in any suitable delivery system, especially those involving delivery over a bare guidewire. [0250]
  • Referring to FIG. 58, there is illustrated a further catheter assembly [0251] 210 according to the invention, which is similar to the assembly 160 of FIG. 50, and similar elements in FIG. 58 are assigned the same reference numerals.
  • The clamp [0252] 220, in this case, is in the form of an end-cap releasably mounted over the distal end of the pod 164.
  • When the [0253] filter 1 has been collapsed down and loaded into the reception space 165, pressure is applied to the pod 164 and/or to the collapsed filter 1. It has been found that by applying such pressures the loading stresses on the collapsed filter 1 and on the pod 164 are more evenly distributed.
  • The pressure may be applied in the radial direction F[0254] 1 and/or in the longitudinal direction F2, and the magnitude of the applied pressure may be varied as desired. In addition, the pressure applied may remain constant over time, or may vary over time, for example in a cyclical manner.
  • Referring to FIGS. 59 and 60 there is illustrated a further [0255] embolic protection filter 400 according to the invention, which is similar to the filter 1 of FIG. 1, and similar elements in FIGS. 59 and 60 are assigned the same reference numerals.
  • In this case, the [0256] filter body 2 has a plurality of small outlet openings 401 at the outlet end 5 of the filter 400 and extending along the filter body 2 towards the inlet end 4, as illustrated in FIG. 59. In FIGS. 59 & 60 I think it is important to make reference to the liquid pores and the gas pores. Both the filter and pod may contain both liquid pores and gas pores. Gas pores provide some back pressure and ensure that no air pockets are generated. A gradient of hole sizes might be used to achieve the best flushing.
  • By providing [0257] outlet openings 401 along the central portion of the filter body 2, this configuration aids in minimising the possibility of the filter 400 creeping or the pod 22 creeping when the filter 400 is loaded within the pod 22 for periods of time, as illustrated in FIG. 60.
  • The invention is not limited to the embodiments hereinbefore described which may be varied in construction and/or detail. [0258]

Claims (103)

1. An embolic protection system comprising:
an embolic protection filter having a collapsed delivery configuration and an expanded deployed configuration;
a delivery catheter having a reception space, an embolic protection filter being housed in the collapsed configuration in the reception space of the delivery catheter; and
a sealed sterile pouch housing the delivery catheter containing the filter in the collapsed configuration.
2. A system as claimed in claim 1 wherein the filter in the collapsed configuration is at least partially folded.
3. A system as claimed in claim 2 wherein the system comprises an adhesion preventer to substantially prevent adhesion of adjacent folds of the filter to one another in the collapsed configuration.
4. A system as claimed in claim 3 wherein the adhesion preventing material is selected from one or more of:
a silicon fluid;
a silicon gel;
a lipid filled fluid/gel;
a heparin filled fluid/gel; and
an aqueous solution.
5. A system as claimed in claim 1 wherein the device comprises a collapsible body and a support structure to support the body in the expanded configuration.
6. A system as claimed in claim 5 wherein the collapsible body is located at least partially externally of the support structure.
7. A system as claimed in claim 5 wherein the support structure is located at least partially externally of the collapsible body.
8. A system as claimed in claim 3 wherein the adhesion preventer is applied to a surface of the filter.
9. A system as claimed in claim 1 wherein the filter has a biocompatible surface.
10. A system as claimed in claim 9 wherein the biocompatible surface is provided as a coating of biocompatible material on the filter.
11. A system as claimed in claim 10 wherein the biocompatible material is a hydrophilic coating.
12. A system as claimed in claim 9 wherein the biocompatible surface is provided on an external surface of the filter.
13. A system as claimed in claim 9 wherein the biocompatible surface is provided on an internal surface of the filter.
14. A system as claimed in any of the claims 5 wherein adjacent folds of the filter are spaced-apart by one or more arms for extending between adjacent folds of the filter.
15. A system as claimed in claim 14 wherein the support structure comprises the arm.
16. A system as claimed in claim 14 wherein the arm is provided by a tool which is suitable to assist loading of the device into a catheter.
17. A method for providing embolic protection during a vascular procedure comprising the steps of:
providing an embolic protection system comprising a sealed sterile pouch containing a delivery catheter with a reception space, an embolic protection filter being housed in the reception space in collapsed configuration;
opening the pouch; and
removing the delivery catheter containing the embolic protection filter in the collapsed configuration from the pouch.
18. A method as claimed in 17 comprising the step of:
flushing the filter in the collapsed configuration within the delivery catheter.
19. A method as claimed in 18 wherein the filter is flushed prior to sealing of the pouch.
20. A method as claimed in 18 wherein the filter is flushed after removal of the delivery catheter containing the filter in the collapsed configuration from the pouch.
21. A method as claimed in claim 17 comprising loading the delivery catheter and filter onto a guidewire.
22. A method as claimed in claim 21 wherein the delivery catheter and filter are loaded onto a guidewire after removal of the delivery catheter containing the filter in the collapsed configuration from the pouch.
23. A method as claimed in claim 17 comprising loading the delivery catheter and filter into a guide catheter.
24. A method as claimed in claim 23 wherein the delivery catheter and filter are loaded into a guide catheter after removal of the delivery catheter from the pouch.
25. A method as claimed in claim 17 comprising the steps of:
advancing a guidewire through a vasculature;
crossing a desired treatment location with the guidewire;
advancing the delivery catheter and filter over the guidewire to deliver the filter to a desired location; and
deploying the filter from the delivery catheter at the desired location.
26. A method as claimed in claim 25 comprising the steps of:
introducing separate from the embolic protection filter an interventional device over the guidewire to the treatment location for carrying out the interventional procedure, embolic material generated during the treatment procedure being captured by the deployed filter; and
withdrawing the filter from the vasculature.
27. A method as claimed in claim 25 wherein the treatment location is a region of stenosis.
28. A method as claimed in claim 26 wherein the interventional procedure includes a balloon dilation of the stenosis while the filter is deployed.
29. A method as claimed in claim 26 wherein the interventional procedure includes placing a stent at the treatment location while the filter is deployed.
30. A method as claimed in claim 25 wherein the guidewire is withdrawn after withdrawal of the filter.
31. A method as claimed in claim 25 wherein the filter comprises a filter body and a filter frame which supports the filter body in the deployed configuration.
32. A method as claimed in claim 25 wherein the filter is slidably disposed on the guidewire when the filter is in the expanded deployed configuration.
33. A method as claimed in 25 wherein the filter is rotatably disposed on the guidewire when the filter is in the expanded deployed configuration.
34. A medical device movable between a collapsed configuration for transport through a vasculature and an expanded configuration for deployment in a vasculature, the device comprising:
a storage space for storing a biocompatible material during transport through a vasculature; and
means to deliver the biocompatible material from the storage space to a surface of the device when deployed in a vasculature.
35. A device as claimed in claim 34 wherein the storage space is provided in a wall of the device.
36. A device as claimed in claim 34 wherein the means to deliver the biocompatible material comprises one or more channels from the storage space to the surface of the device.
37. A device as claimed in claim 36 wherein the channel is a capillary channel.
38. A device as claimed in claim 34 wherein the biocompatible material is delivered to an external surface of the device.
39. A device as claimed in claim 34 wherein the biocompatible material is delivered to an internal surface of the device.
40. A device as claimed in claim 34 wherein the device comprises a delivery actuator to at least partially cause delivery of the biocompatible material from the storage space to the surface of the device.
41. A device as claimed in claim 40 wherein the actuator is at least partially of a temperature memory material.
42. A device as claimed in claim 34 wherein the biocompatible material is a hydrophilic material.
43. A device as claimed in claim 34 wherein the device is an embolic protection filter.
44. A device as claimed in claim 43 wherein the filter has an inlet end and an outlet end, the inlet end having one or more inlet openings sized to allow blood and embolic material enter the filter, the outlet end having a plurality of outlet openings sized to allow through passage of blood but to retain undesired embolic material within the filter.
45. A method of loading a medical device into a catheter, the method comprising the steps of:
collapsing the medical device down to a wrapped configuration;
controlling the wrap of the medical device during collapse; and
positioning the medical device at least partially within the catheter.
46. A method as claimed in claim 45 wherein the medical device is at least partially collapsed down by passing the medical device through a funnel.
47. A method as claimed in claim 46 wherein the wrap of the medical device is at least partially controlled by formations on the funnel.
48. A method as claimed in claim 45 wherein the medical device is at least partially collapsed down by directing a jet of fluid over the medical device.
49. A method as claimed in claim 45 wherein the wrap of the medical device is at least partially controlled by directing a jet of fluid over the medical device.
50. A method as claimed in claim 45 wherein the medical device is at least partially collapsed during positioning of the medical device at least partially within the catheter.
51. A system for loading a medical device into a catheter, the system comprising:
means to collapse a medical device down to a wrapped configuration; and
means to control the wrap of the medical device.
52. A system as claimed in claim 51 wherein the means to collapse comprises a funnel through which a medical device may be passed.
53. A system as claimed in claim 52 wherein the means to control the wrap comprises one or more formations on the funnel.
54. A system as claimed in claim 53 wherein the formation comprises an inward protrusion on a wall of the funnel.
55. A system as claimed in claim 54 wherein the protrusion is in the form of a finger extending from an end of the funnel.
56. A system as claimed in claim 55 wherein the finger extends generally longitudinally.
57. A system as claimed in claim 55 wherein the finger extends generally in a spiral.
58. A system as claimed in claim 55 wherein the finger extends from an outlet end of the funnel.
59. A system as claimed in claim 55 wherein the system comprises four fingers spaced-apart around the circumference of the funnel.
60. A system as claimed in claim 59 wherein the fingers are equi-spaced apart.
61. A system as claimed in claim 51 wherein the means to collapse comprises one or more fluid jets for directing a jet of fluid over the medical device.
62. A system as claimed in claim 51 wherein the means to control the wrap comprises one or more fluid jets for directing a jet of fluid over the medical device.
63. A method of loading a medical device into a catheter, the method comprising the steps of:
collapsing the medical device;
positioning the collapsed medical device at least partially within the catheter; and
flushing a liquid through the catheter and the collapsed medical device.
64. A method as claimed in claim 63 wherein the method comprises the step of sealing the catheter with flushing liquid therein.
65. A method of delivering a medical device to a desired location in a vasculature, the method comprising the steps of:
providing a catheter with a collapsed medical device positioned at least partially within the catheter;
flushing a liquid through the catheter and the collapsed medical device; and
introducing the catheter into a vasculature and advancing the catheter through the vasculature.
66. A method as claimed in claim 63 wherein the method comprises the step of monitoring the extent to which the collapsed medical device has been flushed.
67. A method as claimed in claim 66 wherein the flushing step is terminated when the collapsed medical device has been fully flushed.
68. A method as claimed in claim 63 wherein the liquid is flushed distally through the catheter.
69. A method as claimed in claim 63 wherein the liquid is flushed proximally through the catheter.
70. A method as claimed in claim 63 wherein the liquid is flushed through the catheter by creating a pressure differential across the collapsed medical device.
71. A catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein, a wall of the catheter around the reception space having flushing openings through the wall to facilitate flushing of a collapsed medical device in the reception space.
72. A catheter as claimed in claim 71 wherein the concentration of the flushing openings increases distally along the reception space.
73. A catheter as claimed in claim 71 wherein the concentration of the flushing openings increases proximally along the reception space.
74. A catheter as claimed in claim 71 wherein the concentration of the flushing openings increases from a centre of the reception space towards proximal and distal ends of the reception space.
75. A catheter as claimed in claim 71 wherein the catheter comprises means to indicate the extent of flushing of the reception space.
76. A catheter as claimed in claim 75 wherein the means to indicate comprises one or more perfusion openings in the catheter wall at an end of the reception space.
77. A catheter as claimed in claim 75 wherein the means to indicate is provided by a separate component.
78. A catheter as claimed in claim 77 wherein the means to indicate is provided by a stylet extendable through the catheter.
79. A catheter as claimed in claim 75 wherein the means to indicate comprises an element configured to change colour upon contact with a flushing liquid.
80. A catheter as claimed in claim 79 wherein the element comprises litmus.
81. A catheter as claimed in claim 71 wherein the catheter comprises a seal for sealing the reception space with a collapsed medical device and flushing liquid therein.
82. A catheter as claimed in claim 81 wherein the seal extends along substantially the full length of the catheter.
83. A catheter assembly comprising a catheter as claimed in claim 71 and a collapsible medical device receivable in the reception space of the catheter, the medical device having one or more flushing openings in a body of the medical device to facilitate flushing of the medical device when collapsed in the reception space.
84. An assembly as claimed in claim 83 wherein the medical device body comprises a coiled spring.
85. A catheter assembly comprising:
a catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein; and
means for reinforcing against creep a wall of the catheter around the reception space.
86. An assembly as claimed in claim 85 wherein the means for reinforcing reinforce the catheter wall against longitudinal creep.
87. An assembly as claimed in claim 85 or 86 wherein the means for reinforcing reinforce the catheter wall against radial creep.
88. An assembly as claimed in claim 85 to 87 wherein the means for reinforcing comprises a clamp for positioning around the catheter wall.
89. An assembly as claimed in claim 88 wherein the clamp comprises a sleeve.
90. An assembly as claimed in claim 88 wherein the assembly comprises a tray for the catheter, and the clamp is provided by the tray.
91. An assembly as claimed in claim 88 wherein the clamp is configured to provide non-uniform reinforcement along the catheter wall.
92. An assembly as claimed in claim 91 wherein the clamp comprises one or more formations to provide non-uniform reinforcement along the catheter wall.
93. An assembly as claimed in claim 85 wherein the means for reinforcing comprises one or more reinforcing elements in the catheter wall.
94. An assembly as claimed in claim 93 wherein the catheter wall is of a composite construction.
95. A catheter assembly comprising:
a catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein; and
means for elongating a medical device received in the reception space to resist creeping of the medical device.
96. An assembly as claimed in claim 95 wherein the means for elongating comprises a tensioning wire attachable to a medical device.
97. A method of loading a medical device into a catheter, the method comprising the steps of:
collapsing the medical device;
positioning the collapsed medical device at least partially within the catheter; and
applying pressure to the catheter and/or to the collapsed medical device to distribute loading stresses on the catheter and/or on the collapsed medical device.
98. A method as claimed in claim 97 wherein the pressure is applied longitudinally.
99. A method as claimed in claim 97 wherein the pressure is applied radially.
100. A method as claimed in claim 97 wherein the applied pressure is substantially constant over time.
101. A method as claimed in claim 97 wherein the applied pressure varies over time.
102. A method as claimed in claim 101 wherein the applied pressure varies cyclically over time.
103. A catheter assembly comprising:
a catheter having a reception space at a distal end of the catheter for receiving a collapsed medical device therein; and
means for applying pressure to a wall of the catheter around the reception space and/or to a collapsed medical device received in the reception space to distribute loading stresses in the catheter wall and/or the collapsed medical device.
US10/435,661 2002-05-10 2003-05-12 Embolic protection system Abandoned US20030229374A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/435,661 US20030229374A1 (en) 2002-05-10 2003-05-12 Embolic protection system
US12/259,700 US8123778B2 (en) 2002-05-10 2008-10-28 Embolic protection system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37895802P 2002-05-10 2002-05-10
US10/435,661 US20030229374A1 (en) 2002-05-10 2003-05-12 Embolic protection system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/259,700 Continuation US8123778B2 (en) 2002-05-10 2008-10-28 Embolic protection system

Publications (1)

Publication Number Publication Date
US20030229374A1 true US20030229374A1 (en) 2003-12-11

Family

ID=29420459

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/435,661 Abandoned US20030229374A1 (en) 2002-05-10 2003-05-12 Embolic protection system
US12/259,700 Expired - Fee Related US8123778B2 (en) 2002-05-10 2008-10-28 Embolic protection system

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/259,700 Expired - Fee Related US8123778B2 (en) 2002-05-10 2008-10-28 Embolic protection system

Country Status (7)

Country Link
US (2) US20030229374A1 (en)
EP (1) EP1505929B2 (en)
AT (1) ATE414486T1 (en)
AU (1) AU2003241118A1 (en)
DE (1) DE60324787D1 (en)
IE (1) IE20030353A1 (en)
WO (1) WO2003094788A2 (en)

Cited By (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004405A1 (en) * 2001-10-18 2006-01-05 Amr Salahieh Vascular embolic filter devices and methods of use therefor
US20070191877A1 (en) * 2004-09-17 2007-08-16 Dinh Minh Q Shape memory thin film embolic protection device
US20090012468A1 (en) * 2001-11-07 2009-01-08 Anderson Kent D Distal protection device with local drug infusion by physician to maintain patency
WO2009055782A1 (en) * 2007-10-26 2009-04-30 Possis Medical, Inc. Intravascular guidewire filter system for pulmonary embolism protection and embolism removal or maceration
US20100030257A1 (en) * 2006-12-18 2010-02-04 C.R. Bard, Inc. Jugular femoral vena cava filter system
US7662166B2 (en) 2000-12-19 2010-02-16 Advanced Cardiocascular Systems, Inc. Sheathless embolic protection system
US7662165B2 (en) 1997-11-07 2010-02-16 Salviac Limited Embolic protection device
US7678129B1 (en) 2004-03-19 2010-03-16 Advanced Cardiovascular Systems, Inc. Locking component for an embolic filter assembly
US7678131B2 (en) 2002-10-31 2010-03-16 Advanced Cardiovascular Systems, Inc. Single-wire expandable cages for embolic filtering devices
US7766934B2 (en) 2005-07-12 2010-08-03 Cook Incorporated Embolic protection device with an integral basket and bag
US7771452B2 (en) 2005-07-12 2010-08-10 Cook Incorporated Embolic protection device with a filter bag that disengages from a basket
US7780694B2 (en) 1999-12-23 2010-08-24 Advanced Cardiovascular Systems, Inc. Intravascular device and system
US7780697B2 (en) 1997-11-07 2010-08-24 Salviac Limited Embolic protection system
US7799051B2 (en) 1999-05-07 2010-09-21 Salviac Limited Support frame for an embolic protection device
US7815660B2 (en) 2002-09-30 2010-10-19 Advanced Cardivascular Systems, Inc. Guide wire with embolic filtering attachment
US20100268263A1 (en) * 2009-04-21 2010-10-21 Boston Scientific Scimed, Inc. Embolic protection filters, filter membranes, and methods for making and using the same
US7842064B2 (en) 2001-08-31 2010-11-30 Advanced Cardiovascular Systems, Inc. Hinged short cage for an embolic protection device
US7846175B2 (en) 2006-04-03 2010-12-07 Medrad, Inc. Guidewire and collapsable filter system
US7850708B2 (en) 2005-06-20 2010-12-14 Cook Incorporated Embolic protection device having a reticulated body with staggered struts
US7867273B2 (en) 2007-06-27 2011-01-11 Abbott Laboratories Endoprostheses for peripheral arteries and other body vessels
US20110034951A1 (en) * 2005-04-18 2011-02-10 Salviac Limited Device for loading an embolic protection filter into a catheter
US7892251B1 (en) 2003-11-12 2011-02-22 Advanced Cardiovascular Systems, Inc. Component for delivering and locking a medical device to a guide wire
US7901427B2 (en) 1997-11-07 2011-03-08 Salviac Limited Filter element with retractable guidewire tip
US7918820B2 (en) 1999-12-30 2011-04-05 Advanced Cardiovascular Systems, Inc. Device for, and method of, blocking emboli in vessels such as blood arteries
US7927349B2 (en) 2001-12-21 2011-04-19 Salviac Limited Support frame for an embolic protection device
US7959646B2 (en) 2001-06-29 2011-06-14 Abbott Cardiovascular Systems Inc. Filter device for embolic protection systems
US7959647B2 (en) 2001-08-30 2011-06-14 Abbott Cardiovascular Systems Inc. Self furling umbrella frame for carotid filter
US7972356B2 (en) 2001-12-21 2011-07-05 Abbott Cardiovascular Systems, Inc. Flexible and conformable embolic filtering devices
US7976560B2 (en) 2002-09-30 2011-07-12 Abbott Cardiovascular Systems Inc. Embolic filtering devices
US20110208284A1 (en) * 2010-02-25 2011-08-25 Biotronik Ag Protective sleeve for a medical device, system comprising a protective sleeve and a medical device, and a method for the production thereof
US8016854B2 (en) 2001-06-29 2011-09-13 Abbott Cardiovascular Systems Inc. Variable thickness embolic filtering devices and methods of manufacturing the same
US8109962B2 (en) 2005-06-20 2012-02-07 Cook Medical Technologies Llc Retrievable device having a reticulation portion with staggered struts
US8137377B2 (en) 1999-12-23 2012-03-20 Abbott Laboratories Embolic basket
US8142442B2 (en) 1999-12-23 2012-03-27 Abbott Laboratories Snare
US8152831B2 (en) 2005-11-17 2012-04-10 Cook Medical Technologies Llc Foam embolic protection device
US8177791B2 (en) 2000-07-13 2012-05-15 Abbott Cardiovascular Systems Inc. Embolic protection guide wire
US8182508B2 (en) 2005-10-04 2012-05-22 Cook Medical Technologies Llc Embolic protection device
US8187298B2 (en) 2005-08-04 2012-05-29 Cook Medical Technologies Llc Embolic protection device having inflatable frame
US8205745B2 (en) 2003-08-08 2012-06-26 Hollister Incorporated Vapor hydration of a hydrophilic catheter in a package
US8216269B2 (en) 2005-11-02 2012-07-10 Cook Medical Technologies Llc Embolic protection device having reduced profile
US8216209B2 (en) 2007-05-31 2012-07-10 Abbott Cardiovascular Systems Inc. Method and apparatus for delivering an agent to a kidney
US8221446B2 (en) 2005-03-15 2012-07-17 Cook Medical Technologies Embolic protection device
US8252017B2 (en) 2005-10-18 2012-08-28 Cook Medical Technologies Llc Invertible filter for embolic protection
US8252018B2 (en) 2007-09-14 2012-08-28 Cook Medical Technologies Llc Helical embolic protection device
US8262689B2 (en) 2001-09-28 2012-09-11 Advanced Cardiovascular Systems, Inc. Embolic filtering devices
US8356457B2 (en) 2006-06-08 2013-01-22 Hollister Incorporated Catheter product package and method of forming same
US8377092B2 (en) 2005-09-16 2013-02-19 Cook Medical Technologies Llc Embolic protection device
US8388644B2 (en) 2008-12-29 2013-03-05 Cook Medical Technologies Llc Embolic protection device and method of use
US8419748B2 (en) 2007-09-14 2013-04-16 Cook Medical Technologies Llc Helical thrombus removal device
US8591540B2 (en) 2003-02-27 2013-11-26 Abbott Cardiovascular Systems Inc. Embolic filtering devices
US8632562B2 (en) 2005-10-03 2014-01-21 Cook Medical Technologies Llc Embolic protection device
US20140025083A1 (en) * 2005-02-28 2014-01-23 Boston Scientific Scimed, Inc. Distal release retrieval assembly and related methods of use
US8795322B2 (en) 2002-04-01 2014-08-05 W. L. Gore & Associates, Inc. Methods of manufacture and use of endoluminal devices
US8795315B2 (en) 2004-10-06 2014-08-05 Cook Medical Technologies Llc Emboli capturing device having a coil and method for capturing emboli
US8845583B2 (en) 1999-12-30 2014-09-30 Abbott Cardiovascular Systems Inc. Embolic protection devices
US8945169B2 (en) 2005-03-15 2015-02-03 Cook Medical Technologies Llc Embolic protection device
US9023076B2 (en) 2002-10-17 2015-05-05 W. L. Gore & Associates, Inc. Embolic filter frame having looped support strut elements
US9138307B2 (en) 2007-09-14 2015-09-22 Cook Medical Technologies Llc Expandable device for treatment of a stricture in a body vessel
US9204887B2 (en) 2012-08-14 2015-12-08 W. L. Gore & Associates, Inc. Devices and systems for thrombus treatment
US9259305B2 (en) 2005-03-31 2016-02-16 Abbott Cardiovascular Systems Inc. Guide wire locking mechanism for rapid exchange and other catheter systems
US20160199067A1 (en) * 2015-01-08 2016-07-14 Boston Scientific Scimed, Inc. Medical device with a removable liner
US9901434B2 (en) 2007-02-27 2018-02-27 Cook Medical Technologies Llc Embolic protection device including a Z-stent waist band
US9907639B2 (en) 2006-09-19 2018-03-06 Cook Medical Technologies Llc Apparatus and methods for in situ embolic protection
CN110312481A (en) * 2016-10-24 2019-10-08 伊纳里医疗有限公司 Device and method for treating vascular occlusion
US10434282B2 (en) * 2013-03-14 2019-10-08 Hollister Incorporated Medical product package

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7712606B2 (en) * 2005-09-13 2010-05-11 Sadra Medical, Inc. Two-part package for medical implant
US20070077435A1 (en) * 2005-10-05 2007-04-05 Schachter Deborah M Process for coating a medical device
US9433427B2 (en) 2014-04-08 2016-09-06 Incuvate, Llc Systems and methods for management of thrombosis
US9248221B2 (en) 2014-04-08 2016-02-02 Incuvate, Llc Aspiration monitoring system and method
US10702292B2 (en) 2015-08-28 2020-07-07 Incuvate, Llc Aspiration monitoring system and method
US20170100142A1 (en) 2015-10-09 2017-04-13 Incuvate, Llc Systems and methods for management of thrombosis
US10226263B2 (en) 2015-12-23 2019-03-12 Incuvate, Llc Aspiration monitoring system and method
BR112018072998A2 (en) * 2016-05-09 2019-03-06 Qvanteq Ag provision for storing and charging a self-expanding stent-like device
US10926058B2 (en) 2017-07-17 2021-02-23 Anteris Technologies Corporation Sterilized packaging system for catheter

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US5152777A (en) * 1989-01-25 1992-10-06 Uresil Corporation Device and method for providing protection from emboli and preventing occulsion of blood vessels
US5800525A (en) * 1997-06-04 1998-09-01 Vascular Science, Inc. Blood filter
US5957892A (en) * 1998-03-12 1999-09-28 Specialized Health Products, Inc. Safety catheter insertion apparatus and methods
US6277139B1 (en) * 1999-04-01 2001-08-21 Scion Cardio-Vascular, Inc. Vascular protection and embolic material retriever
US6336934B1 (en) * 1997-11-07 2002-01-08 Salviac Limited Embolic protection device
US6395014B1 (en) * 1997-09-26 2002-05-28 John A. Macoviak Cerebral embolic protection assembly and associated methods
US6461665B1 (en) * 1998-09-09 2002-10-08 Carmeda Ab Process for preparing surface modification substances
US6565591B2 (en) * 2000-06-23 2003-05-20 Salviac Limited Medical device
US6752819B1 (en) * 1998-04-02 2004-06-22 Salviac Limited Delivery catheter

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006878A1 (en) * 1991-10-11 1993-04-15 Boston Scientific Corporation Catheter introducer sheath assembly
US5549626A (en) * 1994-12-23 1996-08-27 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Vena caval filter
US5755709A (en) * 1996-04-25 1998-05-26 Cuppy; Michael J. Catheter system for percutaneously introducing a liquid
US6869938B1 (en) * 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
SE9900465D0 (en) * 1999-02-12 1999-02-12 Astra Ab Storage package
US6168579B1 (en) * 1999-08-04 2001-01-02 Scimed Life Systems, Inc. Filter flush system and methods of use
AU1083101A (en) 1999-10-12 2001-04-23 Allan R. Will Methods and devices for protecting a passageway in a body
GB2369575A (en) 2000-04-20 2002-06-05 Salviac Ltd An embolic protection system
JP2003535641A (en) * 2000-06-23 2003-12-02 サルヴィアック・リミテッド Filter element for embolic protection device
US6485501B1 (en) * 2000-08-11 2002-11-26 Cordis Corporation Vascular filter system with guidewire and capture mechanism

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US5152777A (en) * 1989-01-25 1992-10-06 Uresil Corporation Device and method for providing protection from emboli and preventing occulsion of blood vessels
US5800525A (en) * 1997-06-04 1998-09-01 Vascular Science, Inc. Blood filter
US6395014B1 (en) * 1997-09-26 2002-05-28 John A. Macoviak Cerebral embolic protection assembly and associated methods
US6336934B1 (en) * 1997-11-07 2002-01-08 Salviac Limited Embolic protection device
US5957892A (en) * 1998-03-12 1999-09-28 Specialized Health Products, Inc. Safety catheter insertion apparatus and methods
US6752819B1 (en) * 1998-04-02 2004-06-22 Salviac Limited Delivery catheter
US6461665B1 (en) * 1998-09-09 2002-10-08 Carmeda Ab Process for preparing surface modification substances
US6277139B1 (en) * 1999-04-01 2001-08-21 Scion Cardio-Vascular, Inc. Vascular protection and embolic material retriever
US6565591B2 (en) * 2000-06-23 2003-05-20 Salviac Limited Medical device

Cited By (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785342B2 (en) 1997-11-07 2010-08-31 Salviac Limited Embolic protection device
US7901426B2 (en) 1997-11-07 2011-03-08 Salviac Limited Embolic protection device
US7901427B2 (en) 1997-11-07 2011-03-08 Salviac Limited Filter element with retractable guidewire tip
US8241319B2 (en) 1997-11-07 2012-08-14 Salviac Limited Embolic protection system
US8226678B2 (en) 1997-11-07 2012-07-24 Salviac Limited Embolic protection device
US8221448B2 (en) 1997-11-07 2012-07-17 Salviac Limited Embolic protection device
US8430901B2 (en) 1997-11-07 2013-04-30 Salviac Limited Embolic protection device
US7662165B2 (en) 1997-11-07 2010-02-16 Salviac Limited Embolic protection device
US8216270B2 (en) 1997-11-07 2012-07-10 Salviac Limited Embolic protection device
US7972352B2 (en) 1997-11-07 2011-07-05 Salviac Limited Embolic protection system
US8852226B2 (en) 1997-11-07 2014-10-07 Salviac Limited Vascular device for use during an interventional procedure
US8052716B2 (en) 1997-11-07 2011-11-08 Salviac Limited Embolic protection system
US8057504B2 (en) 1997-11-07 2011-11-15 Salviac Limited Embolic protection device
US7780697B2 (en) 1997-11-07 2010-08-24 Salviac Limited Embolic protection system
US8328842B2 (en) 1997-11-07 2012-12-11 Salviac Limited Filter element with retractable guidewire tip
US7846176B2 (en) 1997-11-07 2010-12-07 Salviac Limited Embolic protection system
US8603131B2 (en) 1997-11-07 2013-12-10 Salviac Limited Embolic protection device
US7842063B2 (en) 1997-11-07 2010-11-30 Salviac Limited Embolic protection device
US7833242B2 (en) 1997-11-07 2010-11-16 Salviac Limited Embolic protection device
US7837701B2 (en) 1997-11-07 2010-11-23 Salviac Limited Embolic protection device
US8123776B2 (en) 1997-11-07 2012-02-28 Salviac Limited Embolic protection system
US7842066B2 (en) 1997-11-07 2010-11-30 Salviac Limited Embolic protection system
US7799051B2 (en) 1999-05-07 2010-09-21 Salviac Limited Support frame for an embolic protection device
US8137377B2 (en) 1999-12-23 2012-03-20 Abbott Laboratories Embolic basket
US8142442B2 (en) 1999-12-23 2012-03-27 Abbott Laboratories Snare
US7780694B2 (en) 1999-12-23 2010-08-24 Advanced Cardiovascular Systems, Inc. Intravascular device and system
US8845583B2 (en) 1999-12-30 2014-09-30 Abbott Cardiovascular Systems Inc. Embolic protection devices
US7918820B2 (en) 1999-12-30 2011-04-05 Advanced Cardiovascular Systems, Inc. Device for, and method of, blocking emboli in vessels such as blood arteries
US8177791B2 (en) 2000-07-13 2012-05-15 Abbott Cardiovascular Systems Inc. Embolic protection guide wire
US7662166B2 (en) 2000-12-19 2010-02-16 Advanced Cardiocascular Systems, Inc. Sheathless embolic protection system
US7931666B2 (en) 2000-12-19 2011-04-26 Advanced Cardiovascular Systems, Inc. Sheathless embolic protection system
US7959646B2 (en) 2001-06-29 2011-06-14 Abbott Cardiovascular Systems Inc. Filter device for embolic protection systems
US8016854B2 (en) 2001-06-29 2011-09-13 Abbott Cardiovascular Systems Inc. Variable thickness embolic filtering devices and methods of manufacturing the same
US7959647B2 (en) 2001-08-30 2011-06-14 Abbott Cardiovascular Systems Inc. Self furling umbrella frame for carotid filter
US7842064B2 (en) 2001-08-31 2010-11-30 Advanced Cardiovascular Systems, Inc. Hinged short cage for an embolic protection device
US8262689B2 (en) 2001-09-28 2012-09-11 Advanced Cardiovascular Systems, Inc. Embolic filtering devices
US20060004405A1 (en) * 2001-10-18 2006-01-05 Amr Salahieh Vascular embolic filter devices and methods of use therefor
US7648518B2 (en) 2001-10-18 2010-01-19 Incept Llc Vascular embolic filter devices and methods of use therefor
US20090012468A1 (en) * 2001-11-07 2009-01-08 Anderson Kent D Distal protection device with local drug infusion by physician to maintain patency
US7972356B2 (en) 2001-12-21 2011-07-05 Abbott Cardiovascular Systems, Inc. Flexible and conformable embolic filtering devices
US7927349B2 (en) 2001-12-21 2011-04-19 Salviac Limited Support frame for an embolic protection device
US8114115B2 (en) 2001-12-21 2012-02-14 Salviac Limited Support frame for an embolic protection device
US8795322B2 (en) 2002-04-01 2014-08-05 W. L. Gore & Associates, Inc. Methods of manufacture and use of endoluminal devices
US8801750B2 (en) 2002-04-01 2014-08-12 W.L. Gore & Associates, Inc. Methods of manufacture and use of endoluminal devices
US7976560B2 (en) 2002-09-30 2011-07-12 Abbott Cardiovascular Systems Inc. Embolic filtering devices
US8029530B2 (en) 2002-09-30 2011-10-04 Abbott Cardiovascular Systems Inc. Guide wire with embolic filtering attachment
US7815660B2 (en) 2002-09-30 2010-10-19 Advanced Cardivascular Systems, Inc. Guide wire with embolic filtering attachment
US9023076B2 (en) 2002-10-17 2015-05-05 W. L. Gore & Associates, Inc. Embolic filter frame having looped support strut elements
US9023077B2 (en) 2002-10-17 2015-05-05 W.L. Gore & Associates, Inc. Embolic filter frame having looped support strut elements
US9642691B2 (en) 2002-10-17 2017-05-09 W. L. Gore & Associates, Inc Vessel occlusion device and method of using same
US7678131B2 (en) 2002-10-31 2010-03-16 Advanced Cardiovascular Systems, Inc. Single-wire expandable cages for embolic filtering devices
US8591540B2 (en) 2003-02-27 2013-11-26 Abbott Cardiovascular Systems Inc. Embolic filtering devices
USRE48426E1 (en) 2003-08-08 2021-02-09 Hollister Incorporated Packaged ready-to-use product
US8205745B2 (en) 2003-08-08 2012-06-26 Hollister Incorporated Vapor hydration of a hydrophilic catheter in a package
US8720685B2 (en) 2003-08-08 2014-05-13 Hollister Incorporated Packaged ready-to-use product and method
US9072862B2 (en) 2003-08-08 2015-07-07 Hollister, Inc. Packaged ready-to-use product
USRE47513E1 (en) 2003-08-08 2019-07-16 Hollister Incorporated Packaged ready-to-use product
US7892251B1 (en) 2003-11-12 2011-02-22 Advanced Cardiovascular Systems, Inc. Component for delivering and locking a medical device to a guide wire
US7678129B1 (en) 2004-03-19 2010-03-16 Advanced Cardiovascular Systems, Inc. Locking component for an embolic filter assembly
US7879065B2 (en) 2004-03-19 2011-02-01 Advanced Cardiovascular Systems, Inc. Locking component for an embolic filter assembly
US8308753B2 (en) 2004-03-19 2012-11-13 Advanced Cardiovascular Systems, Inc. Locking component for an embolic filter assembly
US20070191877A1 (en) * 2004-09-17 2007-08-16 Dinh Minh Q Shape memory thin film embolic protection device
US8795315B2 (en) 2004-10-06 2014-08-05 Cook Medical Technologies Llc Emboli capturing device having a coil and method for capturing emboli
US8979870B2 (en) * 2005-02-28 2015-03-17 Boston Scientific Scimed, Inc. Distal release retrieval assembly and related methods of use
US20140025083A1 (en) * 2005-02-28 2014-01-23 Boston Scientific Scimed, Inc. Distal release retrieval assembly and related methods of use
US8221446B2 (en) 2005-03-15 2012-07-17 Cook Medical Technologies Embolic protection device
US8945169B2 (en) 2005-03-15 2015-02-03 Cook Medical Technologies Llc Embolic protection device
US9259305B2 (en) 2005-03-31 2016-02-16 Abbott Cardiovascular Systems Inc. Guide wire locking mechanism for rapid exchange and other catheter systems
US20110034951A1 (en) * 2005-04-18 2011-02-10 Salviac Limited Device for loading an embolic protection filter into a catheter
US7850708B2 (en) 2005-06-20 2010-12-14 Cook Incorporated Embolic protection device having a reticulated body with staggered struts
US8109962B2 (en) 2005-06-20 2012-02-07 Cook Medical Technologies Llc Retrievable device having a reticulation portion with staggered struts
US8845677B2 (en) 2005-06-20 2014-09-30 Cook Medical Technologies Llc Retrievable device having a reticulation portion with staggered struts
US7867247B2 (en) 2005-07-12 2011-01-11 Cook Incorporated Methods for embolic protection during treatment of a stenotic lesion in a body vessel
US7766934B2 (en) 2005-07-12 2010-08-03 Cook Incorporated Embolic protection device with an integral basket and bag
US7771452B2 (en) 2005-07-12 2010-08-10 Cook Incorporated Embolic protection device with a filter bag that disengages from a basket
US8187298B2 (en) 2005-08-04 2012-05-29 Cook Medical Technologies Llc Embolic protection device having inflatable frame
US8377092B2 (en) 2005-09-16 2013-02-19 Cook Medical Technologies Llc Embolic protection device
US8632562B2 (en) 2005-10-03 2014-01-21 Cook Medical Technologies Llc Embolic protection device
US8182508B2 (en) 2005-10-04 2012-05-22 Cook Medical Technologies Llc Embolic protection device
US8252017B2 (en) 2005-10-18 2012-08-28 Cook Medical Technologies Llc Invertible filter for embolic protection
US8216269B2 (en) 2005-11-02 2012-07-10 Cook Medical Technologies Llc Embolic protection device having reduced profile
US8152831B2 (en) 2005-11-17 2012-04-10 Cook Medical Technologies Llc Foam embolic protection device
US7846175B2 (en) 2006-04-03 2010-12-07 Medrad, Inc. Guidewire and collapsable filter system
US8919553B2 (en) 2006-06-08 2014-12-30 Hollister Incorporated Catheter product package and method of forming same
US8356457B2 (en) 2006-06-08 2013-01-22 Hollister Incorporated Catheter product package and method of forming same
US9907639B2 (en) 2006-09-19 2018-03-06 Cook Medical Technologies Llc Apparatus and methods for in situ embolic protection
US20100030257A1 (en) * 2006-12-18 2010-02-04 C.R. Bard, Inc. Jugular femoral vena cava filter system
US10226322B2 (en) 2006-12-18 2019-03-12 C.R. Bard, Inc. Jugular femoral vena cava filter system
US11213379B2 (en) 2006-12-18 2022-01-04 C.R. Bard, Inc. Jugular femoral vena cava filter system
US8518072B2 (en) * 2006-12-18 2013-08-27 C.R. Bard, Inc. Jugular femoral vena cava filter system
US9393095B2 (en) 2006-12-18 2016-07-19 C.R. Bard, Inc. Jugular femoral vena cava filter system
US9901434B2 (en) 2007-02-27 2018-02-27 Cook Medical Technologies Llc Embolic protection device including a Z-stent waist band
US8216209B2 (en) 2007-05-31 2012-07-10 Abbott Cardiovascular Systems Inc. Method and apparatus for delivering an agent to a kidney
US7867273B2 (en) 2007-06-27 2011-01-11 Abbott Laboratories Endoprostheses for peripheral arteries and other body vessels
US8252018B2 (en) 2007-09-14 2012-08-28 Cook Medical Technologies Llc Helical embolic protection device
US9138307B2 (en) 2007-09-14 2015-09-22 Cook Medical Technologies Llc Expandable device for treatment of a stricture in a body vessel
US8419748B2 (en) 2007-09-14 2013-04-16 Cook Medical Technologies Llc Helical thrombus removal device
US9398946B2 (en) 2007-09-14 2016-07-26 Cook Medical Technologies Llc Expandable device for treatment of a stricture in a body vessel
WO2009055782A1 (en) * 2007-10-26 2009-04-30 Possis Medical, Inc. Intravascular guidewire filter system for pulmonary embolism protection and embolism removal or maceration
US10806559B2 (en) 2007-10-26 2020-10-20 Surmodics Md, Llc Intravascular guidewire filter system for pulmonary embolism protection and embolism removal or maceration
US8657849B2 (en) 2008-12-29 2014-02-25 Cook Medical Technologies Llc Embolic protection device and method of use
US8388644B2 (en) 2008-12-29 2013-03-05 Cook Medical Technologies Llc Embolic protection device and method of use
US20100268263A1 (en) * 2009-04-21 2010-10-21 Boston Scientific Scimed, Inc. Embolic protection filters, filter membranes, and methods for making and using the same
US20110208284A1 (en) * 2010-02-25 2011-08-25 Biotronik Ag Protective sleeve for a medical device, system comprising a protective sleeve and a medical device, and a method for the production thereof
US9204887B2 (en) 2012-08-14 2015-12-08 W. L. Gore & Associates, Inc. Devices and systems for thrombus treatment
US10695084B2 (en) 2012-08-14 2020-06-30 W. L. Gore & Associates, Inc. Devices and systems for thrombus treatment
US11207095B2 (en) 2012-08-14 2021-12-28 W. L. Gore & Associates, Inc. Devices and systems for thrombus treatment
US10434282B2 (en) * 2013-03-14 2019-10-08 Hollister Incorporated Medical product package
US20160199067A1 (en) * 2015-01-08 2016-07-14 Boston Scientific Scimed, Inc. Medical device with a removable liner
CN110312481A (en) * 2016-10-24 2019-10-08 伊纳里医疗有限公司 Device and method for treating vascular occlusion

Also Published As

Publication number Publication date
ATE414486T1 (en) 2008-12-15
US20090254115A1 (en) 2009-10-08
US8123778B2 (en) 2012-02-28
WO2003094788A2 (en) 2003-11-20
AU2003241118A1 (en) 2003-11-11
EP1505929B2 (en) 2013-02-13
EP1505929A1 (en) 2005-02-16
EP1505929B1 (en) 2008-11-19
DE60324787D1 (en) 2009-01-02
IE20030353A1 (en) 2003-11-26

Similar Documents

Publication Publication Date Title
US8123778B2 (en) Embolic protection system
US6544225B1 (en) Embolic coil hydraulic deployment system with purge mechanism
US7083632B2 (en) Aneurysm embolic device with an occlusive member
US6383171B1 (en) Methods and devices for protecting a passageway in a body when advancing devices through the passageway
US9254213B2 (en) Stent delivery device
US4705517A (en) Percutaneously deliverable intravascular occlusion prosthesis
AU774500B2 (en) An embolic protection device
US8852226B2 (en) Vascular device for use during an interventional procedure
US7722634B2 (en) Medical device and method of intravenous filtration
US20060265044A1 (en) Methods and devices for protecting passageway in a body when advancing devices through the passageway
US20030149467A1 (en) Methods, systems and devices for delivering stents
US20040064179A1 (en) Stent delivery device with embolic protection
JP2005516670A (en) Medical equipment
WO2003086525A1 (en) Distal protection double balloon catheter
CN101583318A (en) Collecting sheath and method of use thereof
JP2004160233A (en) Drug eluting stent graft combination
WO2000067664A1 (en) An embolic protection device
US8388645B2 (en) Intravascular filter restraining device
JP2023121165A (en) Embolus material loading catheter, medical appliance set, delivery system, and embolus material delivery medical system

Legal Events

Date Code Title Description
AS Assignment

Owner name: SALVIAC LIMITED, IRELAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BRADY, EAMON;FAHEY, GARY;CASEY, BRENDAN;AND OTHERS;REEL/FRAME:014064/0700;SIGNING DATES FROM 20030508 TO 20030509

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION